Coal workers' pneumoconiosis (CWP, "black lung") is a preventable, progressive occupational interstitial lung disease caused by the inhalation and pulmonary retention of respirable coal mine dust — a heterogeneous mixture of coal, crystalline silica, and other silicate minerals. Particles reaching the distal airways are phagocytosed by alveolar macrophages, whose oxidative and inflammasome-driven response builds the coal macule: a pigmented, dust-laden macrophage collection with reticulin and collagen centred on the respiratory bronchiole, accompanied by focal emphysema. Macules aggregate into radiographically visible micronodules and nodules (simple CWP) and, with sufficient cumulative or silica-rich dust burden, coalesce into conglomerate masses one centimetre or larger — progressive massive fibrosis (PMF, complicated CWP), which can continue to progress after exposure ceases and ends in restrictive or mixed respiratory failure, pulmonary hypertension, and cor pulmonale. Early disease is typically asymptomatic and is detected only by radiographic surveillance. After decades of decline following the 1969 US Federal Coal Mine Health and Safety Act, CWP has resurged since the late 1990s, concentrated in central Appalachia, and contemporary severe cases carry markedly more crystalline silica than their historical counterparts — thin-seam mining requires cutting silica-bearing rock strata. There is no curative therapy; management is supportive, lung transplantation is the only definitive intervention for end-stage disease, and prevention through dust control and surveillance is paramount.
Ask a research question about Coal Workers Pneumoconiosis. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
Conditions with similar clinical presentations that must be differentiated from Coal Workers Pneumoconiosis:
name: Coal Workers Pneumoconiosis
creation_date: "2026-09-03T00:00:00Z"
category: Environmental Lung Disease
parents:
- Pneumoconiosis
- Occupational Lung Disease
disease_term:
preferred_term: coal workers' pneumoconiosis
term:
id: MONDO:0006654
label: anthracosis
description: >-
Coal workers' pneumoconiosis (CWP, "black lung") is a preventable, progressive
occupational interstitial lung disease caused by the inhalation and pulmonary
retention of respirable coal mine dust — a heterogeneous mixture of coal,
crystalline silica, and other silicate minerals. Particles reaching the distal
airways are phagocytosed by alveolar macrophages, whose oxidative and
inflammasome-driven response builds the coal macule: a pigmented, dust-laden
macrophage collection with reticulin and collagen centred on the respiratory
bronchiole, accompanied by focal emphysema. Macules aggregate into
radiographically visible micronodules and nodules (simple CWP) and, with
sufficient cumulative or silica-rich dust burden, coalesce into conglomerate
masses one centimetre or larger — progressive massive fibrosis (PMF, complicated
CWP), which can continue to progress after exposure ceases and ends in
restrictive or mixed respiratory failure, pulmonary hypertension, and cor
pulmonale. Early disease is typically asymptomatic and is detected only by
radiographic surveillance. After decades of decline following the 1969 US
Federal Coal Mine Health and Safety Act, CWP has resurged since the late 1990s,
concentrated in central Appalachia, and contemporary severe cases carry
markedly more crystalline silica than their historical counterparts — thin-seam
mining requires cutting silica-bearing rock strata. There is no curative
therapy; management is supportive, lung transplantation is the only definitive
intervention for end-stage disease, and prevention through dust control and
surveillance is paramount.
classifications:
harrisons_chapter:
- classification_value: RESPIRATORY
ilo_disease_category:
- classification_value: pneumoconiosis_from_fibrogenic_mineral_dust
notes: >-
ILO List of Occupational Diseases (revised 2010), item 2.1.1
"Pneumoconioses caused by fibrogenic mineral dust (silicosis,
anthraco-silicosis, asbestosis)". Coal mine dust is a mixed fibrogenic
mineral dust and the item text names anthraco-silicosis explicitly, which
is the coal-plus-silica pneumoconiosis this entry covers. ILO item 2.1.9
(COPD from coal dust) is deliberately NOT claimed here: that item names a
different disease outcome of the same exposure, curated under Chronic
Obstructive Pulmonary Disease rather than under CWP.
references:
- reference: PMID:41411198
title: "Coal Workers' Pneumoconiosis-Associated Deaths - United States, 2020-2023."
- reference: PMID:35353671
title: "Pathology and Mineralogy Demonstrate Respirable Crystalline Silica Is a Major Cause of Severe Pneumoconiosis in U.S. Coal Miners."
- reference: PMID:35831008
title: "Understanding the pathogenesis of occupational coal and silica dust-associated lung disease."
has_subtypes:
- name: Simple CWP
display_name: Simple (Uncomplicated) Coal Workers' Pneumoconiosis
description: >-
The early form, defined radiographically by small rounded opacities
(ILO profusion categories 1-3) reflecting coal macules and micronodules,
without conglomerate masses. Frequently asymptomatic and detected only on
surveillance radiography, which is what makes periodic screening the key
intervention window.
evidence:
- reference: PMID:41411198
reference_title: "Coal Workers' Pneumoconiosis-Associated Deaths - United States, 2020-2023."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Early pneumoconiosis can be asymptomatic, but advanced disease often leads to disability and premature death."
explanation: >-
Establishes the asymptomatic early stage that distinguishes simple CWP
from the complicated form, and why it is found by screening rather than
by symptoms.
- name: Complicated CWP
display_name: Complicated CWP / Progressive Massive Fibrosis (PMF)
description: >-
Defined by conglomerate fibrotic masses one centimetre or larger (ILO large
opacity categories A, B, C) formed by coalescence of nodular lesions. Carries
a substantially worse prognosis than simple CWP and is characteristically
relentless — it can progress after dust exposure ends. Its prevalence in
long-tenured central Appalachian miners has risen roughly tenfold from a late
1990s nadir.
evidence:
- reference: PMID:35353671
reference_title: "Pathology and Mineralogy Demonstrate Respirable Crystalline Silica Is a Major Cause of Severe Pneumoconiosis in U.S. Coal Miners."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "the prevalence of PMF has increased from 0.33% to 3.2% in miners with 25 years or more of tenure"
explanation: >-
Quantifies the resurgence of the complicated form among long-tenured
central Appalachian miners. Note this sentence sits in the cited paper's
introduction and carries its own citations; the primary surveillance
reports are the source of record for the figure itself.
- reference: PMID:31302880
reference_title: "Current Review of Pneumoconiosis Among US Coal Miners."
supports: SUPPORT
evidence_source: OTHER
snippet: "respiratory morbidity including ongoing fibrosis and functional impairment can occur after exposure ceases"
explanation: >-
Sources the claim that this subtype keeps progressing once dust exposure
has ended, which is what separates its prognosis from simple CWP.
- name: Rapidly Progressive Pneumoconiosis
display_name: Rapidly Progressive Pneumoconiosis (RPP)
description: >-
An accelerated presentation in which radiographic profusion advances unusually
fast, often in younger miners with shorter tenure. Lung pathology in these
cases shows features of accelerated silicosis and mixed-dust lesions with
abundant birefringent silica and silicates rather than the classic
coal-predominant macule, so this subtype is better understood as a
silica-driven variant of coal mine dust lung disease than as fast simple CWP.
evidence:
- reference: PMID:26513613
reference_title: "Lung Pathology in U.S. Coal Workers with Rapidly Progressive Pneumoconiosis Implicates Silica and Silicates."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Thirteen cases were reviewed, many of which had features of accelerated silicosis and mixed dust lesions."
explanation: >-
Documents that rapidly progressive cases carry accelerated-silicosis and
mixed-dust histology rather than the classic coal macule pattern.
- reference: PMID:26513613
reference_title: "Lung Pathology in U.S. Coal Workers with Rapidly Progressive Pneumoconiosis Implicates Silica and Silicates."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Our findings suggest that rapidly progressive pneumoconiosis in these miners was associated with exposure to coal mine dust containing high concentrations of respirable silica and silicates."
explanation: >-
Attributes the rapidly progressive subtype to the silica and silicate
fraction of the dust, the basis for treating it as a distinct subtype.
pathophysiology:
- name: Respirable Coal Mine Dust Deposition and Retention
description: >-
Respirable coal mine dust — a heterogeneous mixture of carbonaceous coal
particles, crystalline silica, and other silicate minerals — is small enough
to escape upper-airway defences and deposit in the terminal bronchioles and
alveoli, beyond the reach of mucociliary clearance. Cumulative retained dust
burden, not any single exposure, is the driving quantity.
role: trigger
biological_scale: TISSUE
locations:
- preferred_term: respiratory bronchiole
term:
id: UBERON:0002188
label: respiratory bronchiole
- preferred_term: pulmonary alveolus
term:
id: UBERON:0002299
label: alveolus of lung
downstream:
- target: Alveolar Macrophage Phagocytosis of Retained Dust
- target: Silica-Enriched Dust Burden
evidence:
- reference: PMID:41411198
reference_title: "Coal Workers' Pneumoconiosis-Associated Deaths - United States, 2020-2023."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Coal workers' pneumoconiosis (CWP) is a preventable, progressive occupational lung disease caused by inhaling respirable coal mine dust, a complex mixture commonly containing coal, crystalline silica, and other silicate minerals."
explanation: >-
Establishes inhaled respirable coal mine dust as the necessary cause and
names the three mineral fractions of the deposited material.
- reference: PMID:35831008
reference_title: "Understanding the pathogenesis of occupational coal and silica dust-associated lung disease."
supports: SUPPORT
evidence_source: OTHER
snippet: "the lesions and macules comprise inhaled coal dust particles engulfed in alveolar macrophages and surrounded by inflammatory cells"
explanation: >-
Establishes that the retained particles are coal dust specifically, sitting
inside alveolar macrophages in the lesion — the deposition-and-retention
step this node represents, rather than a general statement about ambient
particulate matter.
- name: Silica-Enriched Dust Burden
description: >-
The crystalline silica and silicate fraction of the retained dust, which in
contemporary thin-seam mining is markedly higher than historically because
accessing thin coal seams requires cutting silica-bearing rock strata. Silica
is far more cytotoxic and fibrogenic per particle than carbonaceous coal, so
a silica-enriched burden shifts the disease toward the accelerated and
silica-type severe forms rather than merely producing more of the same
lesion.
role: driver
biological_scale: TISSUE
downstream:
- target: Alveolar Macrophage Phagocytosis of Retained Dust
- target: Nodule Coalescence into Progressive Massive Fibrosis
causal_link_type: DIRECT
evidence:
- reference: PMID:37295943
reference_title: "Historical shift in pathological type of progressive massive fibrosis among coal miners in the USA."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "These results are further evidence of the prominent role of RCS in the pathogenesis of pneumoconiosis among contemporary US coal miners."
explanation: >-
Sources the edge from the silica fraction of the retained burden to the
severe conglomerate disease, which is the causal claim this link makes.
evidence:
- reference: PMID:35353671
reference_title: "Pathology and Mineralogy Demonstrate Respirable Crystalline Silica Is a Major Cause of Severe Pneumoconiosis in U.S. Coal Miners."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "In situ mineralogic analysis showed that the percentage (26.1% vs. 17.8%; P < 0.01) and concentration (47.3 × 108 vs. 25.8 × 108 particles/cm3; P = 0.036) of silica particles were significantly greater in specimens from contemporary miners compared with their historical counterparts."
explanation: >-
Directly measures the silica fraction of retained lung dust and shows it
has risen in contemporary miners, which is the mineralogic basis for this
node.
- reference: PMID:26513613
reference_title: "Lung Pathology in U.S. Coal Workers with Rapidly Progressive Pneumoconiosis Implicates Silica and Silicates."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Polarized light microscopy revealed large amounts of birefringent mineral dust particles consistent with silica and silicates; carbonaceous coal dust was less prominent."
explanation: >-
Shows silica and silicates dominating over carbonaceous coal in the
retained dust of severe contemporary cases, supporting a distinct
silica-enriched burden rather than simply more coal.
- reference: PMID:35831008
reference_title: "Understanding the pathogenesis of occupational coal and silica dust-associated lung disease."
supports: SUPPORT
evidence_source: OTHER
snippet: "In contrast to coal dust, silica dust is considered more toxic and potent in eliciting oxidative stress and cellular inflammation in the lungs"
explanation: >-
Sources the comparative-potency half of this node's claim, which the
mineralogy evidence above does not address: the mineralogy says how much
silica is present, this says why that matters per particle.
- name: Alveolar Macrophage Phagocytosis of Retained Dust
description: >-
Alveolar macrophages recognize and internalize the deposited particles in an
attempt to clear them. Coal and silica particles are poorly biodegradable, so
the macrophage cannot resolve the load and instead becomes the persistently
activated cell around which the lesion is built.
role: driver
biological_scale: CELLULAR
cell_types:
- preferred_term: alveolar macrophage
term:
id: CL:0000583
label: alveolar macrophage
biological_processes:
- preferred_term: phagocytosis
term:
id: GO:0006909
label: phagocytosis
modifier: INCREASED
downstream:
- target: Reactive Oxygen Species Generation and Oxidative Injury
- target: Dust-Laden Macrophage Death
evidence:
- reference: PMID:26024344
reference_title: "Small airways involvement in coal mine dust lung disease."
supports: SUPPORT
evidence_source: OTHER
snippet: "Human and laboratory studies have suggested oxidant injury, and increased recruitment and activity of macrophages play important roles in dust-induced lung injury."
explanation: >-
Places increased macrophage recruitment and activity, alongside oxidant
injury, at the centre of coal-dust lung injury.
- reference: PMID:35831008
reference_title: "Understanding the pathogenesis of occupational coal and silica dust-associated lung disease."
supports: SUPPORT
evidence_source: OTHER
snippet: "the lesions and macules comprise inhaled coal dust particles engulfed in alveolar macrophages and surrounded by inflammatory cells"
explanation: >-
States the phagocytic uptake this node annotates: coal dust particles
engulfed by alveolar macrophages, and the lesion built around them.
- name: Reactive Oxygen Species Generation and Oxidative Injury
description: >-
Dust-laden macrophages and the reactive particle surfaces generate reactive
oxygen species that overwhelm local antioxidant defences. Reactive oxygen
species are the shared upstream signal feeding both the inflammasome branch
and the epithelial injury branch of the cascade.
role: driver
biological_scale: CELLULAR
cell_types:
- preferred_term: alveolar macrophage
term:
id: CL:0000583
label: alveolar macrophage
biological_processes:
- preferred_term: reactive oxygen species metabolic process
term:
id: GO:0072593
label: reactive oxygen species metabolic process
modifier: INCREASED
downstream:
- target: Macrophage Mitochondrial Dysfunction and Defective Mitophagy
- target: NF-kappaB and NLRP3 Inflammasome Activation
causal_link_type: DIRECT
evidence:
- reference: PMID:36581638
reference_title: "Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "ROS can induce the activation of AKT/GSK3β signaling, and inhibition of it can inhibit ROS-induced inflammation and EMT by the NF-kB/NLRP3 axis, thereby inhibiting PF."
explanation: >-
Sources this specific edge from the study's own inhibition experiments:
blocking the pathway between reactive oxygen species and NF-kappaB/NLRP3
abolishes the downstream inflammation, which is what makes it an edge
rather than a correlation.
- target: Alveolar Epithelial Injury and Epithelial-Mesenchymal Transition
causal_link_type: DIRECT
evidence:
- reference: PMID:36581638
reference_title: "Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "activation of the IGF1/IGF1R axis induced generation of reactive oxygen species (ROS) to promote epithelial-mesenchymal transition (EMT) in alveolar epithelial cells (AECs) to accelerate PF"
explanation: >-
Sources this specific edge: reactive oxygen species promoting
epithelial-mesenchymal transition in alveolar epithelial cells.
evidence:
- reference: PMID:15364596
reference_title: "Lung oxidative response after acute coal dust exposure."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "TBARS were increased 60 days after coal dust exposure and protein carbonyl groups increased at all times after coal dust exposure (48 h, 7 days, 30 days, and 60 days)."
explanation: >-
Direct in vivo measurement of lipid peroxidation and protein oxidation in
coal-dust-exposed lung, which is the oxidative injury this node asserts
rather than an inference from a signalling pathway in one cell type.
- reference: PMID:36581638
reference_title: "Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "activation of the IGF1/IGF1R axis induced generation of reactive oxygen species (ROS) to promote epithelial-mesenchymal transition (EMT) in alveolar epithelial cells (AECs) to accelerate PF"
explanation: >-
Supports the edge from reactive oxygen species to epithelial-mesenchymal
transition in alveolar epithelial cells, one of the two branches this node
feeds. Note this branch is epithelial; the macrophage-derived and
particle-surface oxidant claim rests on the in vivo item above.
- reference: PMID:36581638
reference_title: "Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "ROS induced inflammation and EMT by the activation of the NF-kB/NLRP3 axis to accelerate PF"
explanation: >-
Supports the other branch: reactive oxygen species acting through the
NF-kappaB/NLRP3 axis to drive inflammation.
- name: Macrophage Mitochondrial Dysfunction and Defective Mitophagy
description: >-
Coal-silica dust collapses mitochondrial membrane potential and impairs
oxidative phosphorylation in macrophages, while suppressing PINK1/Parkin
signalling so the damaged mitochondria are not cleared. The failure of
mitochondrial quality control amplifies the oxidant load and feeds both
macrophage death and the inflammatory output, rather than being a passive
consequence of them.
role: driver
biological_scale: CELLULAR
cell_types:
- preferred_term: alveolar macrophage
term:
id: CL:0000583
label: alveolar macrophage
biological_processes:
- preferred_term: mitophagy
term:
id: GO:0000423
label: mitophagy
modifier: DECREASED
downstream:
- target: Dust-Laden Macrophage Death
- target: Sustained Inflammatory Cell Recruitment and Amplification
evidence:
- reference: PMID:41894156
reference_title: "Activation of Mitophagy by Kinetin Mitigates Coal-Silica Mixed Dust-Induced Pulmonary Fibrosis via Modulating Macrophage Mitochondrial Function in Mice."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "CSD exposure triggered ROS accumulation, mitochondrial membrane potential collapse, and impaired oxidative phosphorylation, leading to reduced adenosine triphosphate synthesis."
explanation: >-
Measures the mitochondrial dysfunction this node asserts, in a
coal-silica mixed dust exposure rather than in a generic particulate
model.
- reference: PMID:41894156
reference_title: "Activation of Mitophagy by Kinetin Mitigates Coal-Silica Mixed Dust-Induced Pulmonary Fibrosis via Modulating Macrophage Mitochondrial Function in Mice."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "CSD suppressed PINK1/Parkin signaling and diminished LC3B mitochondrial recruitment, resulting in defective mitophagy"
explanation: >-
Sources the defective-mitophagy half of the node and names the pathway
through which clearance fails.
notes: >-
Demonstrated in mice and cells, not in human coal miner tissue, and the
branch was added on a reviewer's suggestion after the report flagged its
translational status as unconfirmed. It is curated because the rescue arm
below makes it a testable causal claim rather than an observation, but the
human evidence is not there yet.
- name: Dust-Laden Macrophage Death
description: >-
Poorly biodegradable particles — the silica fraction especially — are
cytotoxic to the macrophages that ingested them, and pro-apoptotic signalling
rises in the alveolar compartment after coal dust exposure. Particles freed by
dying cells are available for re-uptake by newly recruited macrophages, a loop
that keeps the lesion building without further inhaled dust. How much of the
early injury this cell death actually accounts for is contested; see the
refuting evidence below.
role: driver
biological_scale: CELLULAR
cell_types:
- preferred_term: alveolar macrophage
term:
id: CL:0000583
label: alveolar macrophage
biological_processes:
- preferred_term: apoptotic process
term:
id: GO:0006915
label: apoptotic process
modifier: INCREASED
downstream:
- target: Alveolar and Small-Airway Tissue Injury
evidence:
- reference: PMID:16966090
reference_title: "Apoptosis and Bax expression are increased by coal dust in the polycyclic aromatic hydrocarbon-exposed lung."
supports: SUPPORT
directness: INDIRECT
evidence_source: MODEL_ORGANISM
snippet: "In rats exposed to BNF, CD exposure increased alveolar expression of the proapoptotic mediator Bax but decreased CYP1A1 induction relative to BNF exposure alone."
explanation: >-
Indirect on two counts, both material. The pro-apoptotic response is
measured under co-exposure to beta-naphthoflavone rather than to coal dust
alone, and the assay localizes to alveolar cells generally rather than to
macrophages specifically. Quoted in full so the conditional survives.
- reference: PMID:16966090
reference_title: "Apoptosis and Bax expression are increased by coal dust in the polycyclic aromatic hydrocarbon-exposed lung."
supports: REFUTE
evidence_source: MODEL_ORGANISM
snippet: "Combined BNF and CD exposure increased Bax expression and apoptosis in the lung, but Bax and apoptosis were not the major determinants of early lung injury in this model."
explanation: >-
The same study's own conclusion argues against apoptosis being the main
driver of early injury. Curated as a REFUTE item rather than omitted,
because the supporting quote above comes from the same paper and reading
one without the other would overstate the node.
- name: Alveolar and Small-Airway Tissue Injury
description: >-
The cumulative tissue-level result of retained dust, macrophage death and
oxidant exposure: structural and functional damage concentrated in the
alveoli and the small conducting airways, which is where the dust sits and
where the reparative program is then triggered.
role: driver
conforms_to: "fibrotic_response#Tissue Injury"
biological_scale: TISSUE
locations:
- preferred_term: respiratory bronchiole
term:
id: UBERON:0002188
label: respiratory bronchiole
biological_processes:
- preferred_term: wound healing
term:
id: GO:0042060
label: wound healing
modifier: DYSREGULATED
downstream:
- target: Sustained Inflammatory Cell Recruitment and Amplification
evidence:
- reference: PMID:26024344
reference_title: "Small airways involvement in coal mine dust lung disease."
supports: SUPPORT
evidence_source: OTHER
snippet: "Inhalation of coal mine dust results in a spectrum of symptoms, dysfunction, and pathological changes in the respiratory tract that collectively have been labeled coal mine dust lung disease."
explanation: >-
Sources the tissue-injury claim this node makes, and the coal mine dust
lung disease framing under which the injury is classified.
- reference: PMID:26024344
reference_title: "Small airways involvement in coal mine dust lung disease."
supports: SUPPORT
evidence_source: OTHER
snippet: "Pathologic changes associated with mineral dust deposition in the small airways may be of particular importance in contemporary miners with rapidly progressive respiratory impairment."
explanation: >-
Localizes the injury to the small airways, the anatomical claim this node
makes, and ties it to the contemporary rapidly progressive presentation.
- name: NF-kappaB and NLRP3 Inflammasome Activation
description: >-
Reactive oxygen species and retained particles activate NF-kappaB signalling
and assembly of the NLRP3 inflammasome in macrophages and epithelial cells,
activating caspase-1 and releasing mature IL-1beta and IL-18. This converts
a particle-handling problem into a sustained cytokine signal.
role: driver
biological_scale: CELLULAR
cell_types:
- preferred_term: alveolar macrophage
term:
id: CL:0000583
label: alveolar macrophage
biological_processes:
- preferred_term: NLRP3 inflammasome complex assembly
term:
id: GO:0044546
label: NLRP3 inflammasome complex assembly
modifier: INCREASED
- preferred_term: positive regulation of canonical NF-kappaB signal transduction
term:
id: GO:0043123
label: positive regulation of canonical NF-kappaB signal transduction
modifier: INCREASED
downstream:
- target: Sustained Inflammatory Cell Recruitment and Amplification
evidence:
- reference: PMID:36581638
reference_title: "Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "the protein levels of p-NF-κB(Ser536)/NF-κB, NLRP3 and Cleaved Caspase1(Asp297)/Caspase1 in the lung tissues, as well as the contents of IL-1β and CXCL2 in the bronchoalveolar lavage fluid, were significantly increased in CD-NPs-induced pre-fibrosis model mice"
explanation: >-
The study's own in vivo measurement of every component this node asserts —
NF-kappaB phosphorylation, NLRP3, cleaved caspase-1 and the IL-1beta
output — in coal-dust-exposed mouse lung.
- reference: PMID:36581638
reference_title: "Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "p-NF-κB(Ser536)/NF-κB was significantly increased in the CD-NPs-induced pre-fibrotic cell model and could be inhibited by PPP for 24 h"
explanation: >-
The cell-model counterpart, with pharmacological inhibition establishing
that the NF-kappaB activation is coal-dust-driven rather than incidental.
- name: Sustained Inflammatory Cell Recruitment and Amplification
description: >-
IL-1beta, IL-18, TNF-alpha and chemokines recruit neutrophils and further
macrophages to the peribronchiolar region. Because the retained dust is never
cleared, the recruitment does not resolve, and the small airways carry the
signature chronic inflammatory change of coal miners' lungs.
role: driver
conforms_to: "fibrotic_response#Inflammatory Recruitment and Amplification"
biological_scale: TISSUE
cell_types:
- preferred_term: neutrophil
term:
id: CL:0000775
label: neutrophil
- preferred_term: alveolar macrophage
term:
id: CL:0000583
label: alveolar macrophage
biological_processes:
- preferred_term: chronic inflammatory response
term:
id: GO:0002544
label: chronic inflammatory response
modifier: INCREASED
- preferred_term: leukocyte migration
term:
id: GO:0050900
label: leukocyte migration
modifier: INCREASED
locations:
- preferred_term: respiratory bronchiole
term:
id: UBERON:0002188
label: respiratory bronchiole
downstream:
- target: Fibroblast Activation and Myofibroblast Differentiation
- target: Chronic cough
causal_link_type: DIRECT
evidence:
- reference: PMID:26024344
reference_title: "Small airways involvement in coal mine dust lung disease."
supports: SUPPORT
evidence_source: OTHER
snippet: "There is increasing evidence supporting an important association of abnormalities in the small peripheral airways with the development of respiratory symptoms"
explanation: >-
Sources this specific edge: small-airway abnormality producing
respiratory symptoms, of which chronic cough is the characteristic one.
evidence:
- reference: PMID:26024344
reference_title: "Small airways involvement in coal mine dust lung disease."
supports: SUPPORT
evidence_source: OTHER
snippet: "Inflammatory changes in the small airways have long been recognized as the signature lung pathology among coal miners."
explanation: >-
Establishes sustained small-airway inflammation as the defining, and
anatomically localized, pathology of coal miners' lungs.
- reference: PMID:36581638
reference_title: "Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "the contents of IL-1β and CXCL2 in the bronchoalveolar lavage fluid, were significantly increased in CD-NPs-induced pre-fibrosis model mice"
explanation: >-
Measures the neutrophil chemokine CXCL2 and IL-1beta in coal-dust-exposed
mouse airway fluid, the recruitment signal this node claims rather than a
background statement about inflammasomes generally.
- name: Alveolar Epithelial Injury and Epithelial-Mesenchymal Transition
description: >-
Injured alveolar epithelial cells undergo epithelial-mesenchymal transition,
losing epithelial identity and acquiring a mesenchymal, matrix-producing
phenotype. This is a second route into the fibroblast pool, parallel to
activation of resident fibroblasts by the inflammatory milieu.
role: driver
biological_scale: CELLULAR
cell_types:
- preferred_term: alveolar type II epithelial cell
term:
id: CL:0002063
label: pulmonary alveolar type 2 cell
biological_processes:
- preferred_term: epithelial to mesenchymal transition
term:
id: GO:0001837
label: epithelial to mesenchymal transition
modifier: INCREASED
downstream:
- target: Fibroblast Activation and Myofibroblast Differentiation
causal_link_type: DIRECT
evidence:
- reference: PMID:36581638
reference_title: "Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "the protein levels of COL-1, COL-3, and α-SMA were highest in the CD-NPs-induced cell model"
explanation: >-
Sources this specific edge by its output: coal dust exposure raises
alpha-SMA (the myofibroblast marker) together with collagen I and III in
the same model that shows the transition.
evidence:
- reference: PMID:36581638
reference_title: "Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "The above data indicated that inhibition of NLRP3 reversed EMT induced by CD-NPs."
explanation: >-
The study's own loss-of-function result: blocking NLRP3 abolishes the
coal-dust-induced transition, establishing this node as downstream of the
inflammasome rather than merely coincident with it.
- reference: PMID:36581638
reference_title: "Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "CD-NPs induced PF by promoting inflammation and EMT via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals."
explanation: >-
The study's overall conclusion, placing epithelial-mesenchymal transition
downstream of coal dust and upstream of pulmonary fibrosis. Demonstrated
with coal dust nanoparticles in cell and mouse systems; that nanoparticle
fraction is a component of, not a substitute for, the respirable coal mine
dust miners inhale.
- name: Fibroblast Activation and Myofibroblast Differentiation
description: >-
Resident lung fibroblasts, together with cells arriving via
epithelial-mesenchymal transition, differentiate into alpha-smooth-muscle-actin
positive myofibroblasts under TGF-beta and inflammatory cytokine signalling.
This is the central effector step: from here the lesion is matrix, not
inflammation.
role: central_effector
conforms_to: "fibrotic_response#Mesenchymal Cell Activation"
biological_scale: CELLULAR
cell_types:
- preferred_term: lung fibroblast
term:
id: CL:0002553
label: fibroblast of lung
- preferred_term: myofibroblast
term:
id: CL:0000186
label: myofibroblast cell
biological_processes:
- preferred_term: transforming growth factor beta receptor signaling pathway
term:
id: GO:0007179
label: transforming growth factor beta receptor signaling pathway
modifier: INCREASED
downstream:
- target: Peribronchiolar Collagen Deposition and Coal Macule Formation
causal_link_type: DIRECT
evidence:
- reference: PMID:35831008
reference_title: "Understanding the pathogenesis of occupational coal and silica dust-associated lung disease."
supports: SUPPORT
evidence_source: OTHER
snippet: "activate fibroblasts, which increase the production of extracellular matrix proteins, leading to collagen deposition and eventual scarring of lung tissue"
explanation: >-
Sources this specific edge: activated fibroblasts are what raise
extracellular matrix production and deposit the collagen that builds the
lesion.
evidence:
- reference: PMID:36581638
reference_title: "Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "the protein levels of COL-1, COL-3, and α-SMA were highest in the CD-NPs-induced cell model"
explanation: >-
Directly measures the alpha-SMA-positive myofibroblast phenotype and its
collagen output after coal dust exposure — the node's central claim, from
the study's own results rather than its background.
- reference: PMID:35831008
reference_title: "Understanding the pathogenesis of occupational coal and silica dust-associated lung disease."
supports: SUPPORT
evidence_source: OTHER
snippet: "activate fibroblasts, which increase the production of extracellular matrix proteins, leading to collagen deposition and eventual scarring of lung tissue"
explanation: >-
Sources the inflammation-to-fibroblast-activation step this node sits at,
from a review of coal and silica dust lung disease specifically rather
than from generic pulmonary-fibrosis background. The same passage names
TGF-beta among the mediators produced, which is the signalling annotated
here.
- name: Peribronchiolar Collagen Deposition and Coal Macule Formation
description: >-
Myofibroblasts deposit collagen and reticulin around the dust-laden
macrophage collection at the respiratory bronchiole, producing the coal
macule — the histopathologic hallmark lesion of CWP. Macules aggregate into
micronodules and nodules that become visible as small rounded opacities on
chest radiography, defining simple CWP.
role: consequence
conforms_to: "fibrotic_response#Excessive ECM Deposition"
biological_scale: TISSUE
locations:
- preferred_term: respiratory bronchiole
term:
id: UBERON:0002188
label: respiratory bronchiole
biological_processes:
- preferred_term: extracellular matrix organization
term:
id: GO:0030198
label: extracellular matrix organization
modifier: INCREASED
- preferred_term: collagen biosynthetic process
term:
id: GO:0032964
label: collagen biosynthetic process
modifier: INCREASED
downstream:
- target: Focal Centrilobular Emphysema
- target: Nodule Coalescence into Progressive Massive Fibrosis
causal_link_type: DIRECT
evidence:
- reference: PMID:37295943
reference_title: "Historical shift in pathological type of progressive massive fibrosis among coal miners in the USA."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Excessive coal mine dust exposure can lead to coal workers' pneumoconiosis (CWP), including its most severe form, progressive massive fibrosis (PMF)."
explanation: >-
Places progressive massive fibrosis as the severe end of the same
dust-driven disease process that produces the macular lesion, which is
the progression this edge asserts.
- target: Pulmonary nodule
evidence:
- reference: PMID:26024344
reference_title: "Small airways involvement in coal mine dust lung disease."
supports: SUPPORT
evidence_source: OTHER
snippet: "The coal macule is an inflammatory lesion associated with deposited dust, and occurs in the region of the most distal conducting airways and proximal respiratory bronchioles."
explanation: >-
Defines the hallmark lesion and fixes its anatomical location at the
respiratory bronchiole, which is the location bound on this node.
- name: Focal Centrilobular Emphysema
description: >-
Destruction of alveolar walls immediately around the coal macule produces
focal centrilobular emphysema. This is the obstructive component of coal mine
dust lung disease and runs alongside the restrictive fibrotic component
rather than replacing it, which is why advanced disease is characteristically
a mixed defect.
role: consequence
biological_scale: TISSUE
downstream:
- target: Impaired Gas Exchange and Mixed Ventilatory Defect
- target: Emphysema
evidence:
- reference: PMID:35831008
reference_title: "Understanding the pathogenesis of occupational coal and silica dust-associated lung disease."
supports: SUPPORT
evidence_source: OTHER
snippet: "coal macules or lesions <10 mm in diameter occurring mostly in the upper lung lobes due to the accumulation of dust particles and dust-laden macrophages are usually associated with focal centrilobular emphysema"
explanation: >-
Sources the morphologic claim this node actually makes — focal
centrilobular emphysema arising around the macule — and with it the
incoming edge from coal macule formation.
- reference: PMID:24186945
reference_title: "Respiratory disease mortality among US coal miners; results after 37 years of follow-up."
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
snippet: "Coal mine dust exposure increased risk for mortality from pneumoconiosis and COPD."
explanation: >-
Indirect: establishes an obstructive disease burden attributable to coal
mine dust at the population level, from which the emphysematous substrate
follows, rather than reporting the morphology itself.
- reference: PMID:24186945
reference_title: "Respiratory disease mortality among US coal miners; results after 37 years of follow-up."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Our findings support previous studies showing that exposure to coal mine dust and respirable silica leads to increased mortality from malignant and non-malignant respiratory diseases even in the absence of smoking."
explanation: >-
Shows the excess respiratory mortality persists in the absence of smoking,
so the obstructive component is dust-driven rather than a confounded
smoking effect.
- name: Nodule Coalescence into Progressive Massive Fibrosis
description: >-
Nodular lesions coalesce into conglomerate fibrotic masses one centimetre or
larger, destroying regional lung architecture. PMF is the disabling
complicated form and is characteristically self-sustaining: it can continue
to progress after dust exposure has ended. The silica-enriched dust burden of
contemporary mining shifts the histologic type of these masses toward
silica-type PMF.
role: consequence
conforms_to: "fibrotic_response#Architectural Distortion and Organ Dysfunction"
biological_scale: TISSUE
locations:
- preferred_term: lung
term:
id: UBERON:0002048
label: lung
downstream:
- target: Impaired Gas Exchange and Mixed Ventilatory Defect
causal_link_type: DIRECT
evidence:
- reference: PMID:41411198
reference_title: "Coal Workers' Pneumoconiosis-Associated Deaths - United States, 2020-2023."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Early pneumoconiosis can be asymptomatic, but advanced disease often leads to disability and premature death."
explanation: >-
Sources the edge from advanced conglomerate disease to disabling
functional impairment and death.
- target: Pulmonary fibrosis
evidence:
- reference: PMID:37295943
reference_title: "Historical shift in pathological type of progressive massive fibrosis among coal miners in the USA."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Of 322 cases found to have PMF, study pathologists characterised 138 (43%) as coal-type, 129 (40%) as mixed-type and 55 (17%) as silica-type PMF."
explanation: >-
Establishes the histologic typing of PMF masses in autopsy material and
the relative frequency of each type.
- reference: PMID:37295943
reference_title: "Historical shift in pathological type of progressive massive fibrosis among coal miners in the USA."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Our findings demonstrate a shift in PMF types among US coal miners, from a predominance of coal- and mixed-type PMF to a more commonly encountered silica-type PMF."
explanation: >-
Supports the edge from the silica-enriched dust burden node to this one:
more silica in the dust changes the type of mass that forms.
- reference: PMID:35353671
reference_title: "Pathology and Mineralogy Demonstrate Respirable Crystalline Silica Is a Major Cause of Severe Pneumoconiosis in U.S. Coal Miners."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We found a significantly higher proportion of silica-type PMF (57% vs. 18%; P < 0.001) among contemporary miners compared with their historical counterparts."
explanation: >-
Independent case series quantifying the same contemporary shift toward
silica-type PMF.
- reference: PMID:41411198
reference_title: "Coal Workers' Pneumoconiosis-Associated Deaths - United States, 2020-2023."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Disease progression can occur after cessation of exposure"
explanation: >-
Sources the self-sustaining behaviour this node claims, which is the
property that makes progressive massive fibrosis different from a lesion
that simply stops accruing when the dust stops.
- reference: PMID:31302880
reference_title: "Current Review of Pneumoconiosis Among US Coal Miners."
supports: SUPPORT
evidence_source: OTHER
snippet: "respiratory morbidity including ongoing fibrosis and functional impairment can occur after exposure ceases"
explanation: >-
Independent statement of the same post-cessation progression, naming
ongoing fibrosis specifically rather than progression in general.
- name: Impaired Gas Exchange and Mixed Ventilatory Defect
description: >-
Fibrotic mass lesions restrict lung expansion while focal emphysema and small
airway disease obstruct airflow, producing the mixed restrictive-obstructive
physiology and ventilation-perfusion mismatch of advanced CWP. Progressive
hypoxemia follows, and chronic hypoxic vasoconstriction with vascular
destruction raises pulmonary artery pressure toward cor pulmonale.
role: consequence
biological_scale: ORGANISM
downstream:
- target: Exertional dyspnea
- target: Restrictive ventilatory defect
- target: Airway obstruction
- target: Hypoxemia
- target: Elevated pulmonary artery pressure
evidence:
- reference: PMID:37284491
reference_title: "Serum Osteopontin, KL-6, and Syndecan-4 as Potential Biomarkers in the Diagnosis of Coal Workers' Pneumoconiosis: A Case-Control Study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The pulmonary function parameters decreased sequentially, and the serum OPN, KL-6, Syndecan-4 and Gremlin-1 concentrations were increased sequentially among the HC, DEW and CWP groups."
explanation: >-
Shows measured pulmonary function declining stepwise from healthy controls
through dust-exposed workers to CWP patients, grounding the functional
impairment claim in a graded human series.
- reference: PMID:41411198
reference_title: "Coal Workers' Pneumoconiosis-Associated Deaths - United States, 2020-2023."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Early pneumoconiosis can be asymptomatic, but advanced disease often leads to disability and premature death."
explanation: >-
Supports the progression from a silent early lesion to disabling
functional impairment that this node represents.
phenotypes:
- name: Pulmonary nodule
category: Respiratory
description: >-
Small rounded opacities on chest radiography, graded by the ILO
classification for profusion and size, corresponding to coal macules and
micronodules. This is the defining radiographic finding of simple CWP and,
because early disease is symptomless, usually the first sign of it.
phenotype_term:
preferred_term: Pulmonary nodule
term:
id: HP:0033608
label: Pulmonary nodule
evidence:
- reference: PMID:31302880
reference_title: "Current Review of Pneumoconiosis Among US Coal Miners."
supports: SUPPORT
evidence_source: OTHER
snippet: "Extended exposure to the dust that is generated in the process of extracting coal can cause interstitial fibrosis of the lungs that can be visualized by chest radiography."
explanation: >-
Sources the radiographic detectability of the dust-induced parenchymal
lesion on which this phenotype and the whole surveillance program rest.
- reference: PMID:36972614
reference_title: "Pathology and Mineralogy of the Pneumoconioses."
supports: SUPPORT
evidence_source: OTHER
snippet: "Pathologic studies have shown that rounded opacities on chest imaging correspond to coal macules and coal nodules, and irregular opacities to interstitial fibrosis."
explanation: >-
Ties the radiographic nodule to the coal macule and nodule specifically,
the lesion this phenotype names.
- name: Pulmonary fibrosis
category: Respiratory
description: >-
Interstitial fibrosis of the lung, ranging from the reticulin and collagen of
individual coal macules to the conglomerate masses of progressive massive
fibrosis.
phenotype_term:
preferred_term: Pulmonary fibrosis
term:
id: HP:0002206
label: Pulmonary fibrosis
evidence:
- reference: PMID:27626436
reference_title: "Polymorphisms in Long Noncoding RNA H19 Contribute to the Protective Effects of Coal Workers' Pneumoconiosis in a Chinese Population."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "pneumoconiosis (CWP) is a lethal fibrotic lung disease caused by inhalation and deposition of inorganic coal mine dust in the lung"
explanation: >-
Characterizes CWP as a fibrotic lung disease, the substrate of this
phenotype.
- name: Exertional dyspnea
category: Respiratory
description: >-
Progressive breathlessness on exertion, the dominant symptom of complicated
disease and the usual reason a miner presents. Absent or minimal in simple
CWP.
phenotype_term:
preferred_term: Exertional dyspnea
term:
id: HP:0002875
label: Exertional dyspnea
frequency: FREQUENT
evidence:
- reference: PMID:35831008
reference_title: "Understanding the pathogenesis of occupational coal and silica dust-associated lung disease."
supports: SUPPORT
evidence_source: OTHER
snippet: "This is associated with increased collagen deposition and fibrosis around the airways and within the parenchyma, exertional breathlessness, haemoptysis and lung scarring."
explanation: >-
Names exertional breathlessness directly as a manifestation of the
dust-driven fibrosis, which the mortality statistics used elsewhere in
this entry do not.
- reference: PMID:35831008
reference_title: "Understanding the pathogenesis of occupational coal and silica dust-associated lung disease."
supports: SUPPORT
evidence_source: OTHER
snippet: "Patients with PMF often experience increasing breathlessness and severe deterioration in lung function"
explanation: >-
Sources the progression of breathlessness specifically in the complicated
form, matching this phenotype's description.
- name: Chronic cough
category: Respiratory
description: >-
Persistent cough, frequently productive, reflecting chronic small-airway
inflammation from retained dust.
phenotype_term:
preferred_term: Chronic cough
term:
id: HP:0034315
label: Chronic cough
evidence:
- reference: PMID:26024344
reference_title: "Small airways involvement in coal mine dust lung disease."
supports: SUPPORT
evidence_source: OTHER
snippet: "There is increasing evidence supporting an important association of abnormalities in the small peripheral airways with the development of respiratory symptoms"
explanation: >-
Links the small-airway pathology of CWP to respiratory symptoms, the
mechanistic basis for cough in this disease.
- reference: PMID:35831008
reference_title: "Understanding the pathogenesis of occupational coal and silica dust-associated lung disease."
supports: SUPPORT
evidence_source: OTHER
snippet: "as the disease manifests, patients exhibit symptoms of coughing, sneezing, increased sputum production, breathlessness and breathing difficulties"
explanation: >-
Names cough and increased sputum production directly among the symptoms of
manifest CWP, which the mechanistic quote above does not.
- name: Emphysema
category: Respiratory
description: >-
Focal centrilobular emphysema surrounding coal macules, plus more diffuse
dust-related emphysema. Present in never-smoking miners, so it is a
dust-attributable finding rather than a smoking comorbidity.
phenotype_term:
preferred_term: Focal centrilobular emphysema
term:
id: HP:0032966
label: Centrilobular emphysema
evidence:
- reference: PMID:35831008
reference_title: "Understanding the pathogenesis of occupational coal and silica dust-associated lung disease."
supports: SUPPORT
evidence_source: OTHER
snippet: "coal macules or lesions <10 mm in diameter occurring mostly in the upper lung lobes due to the accumulation of dust particles and dust-laden macrophages are usually associated with focal centrilobular emphysema"
explanation: >-
Names the centrilobular distribution and its association with the coal
macule, which is why this phenotype binds the centrilobular child term
rather than the generic Emphysema parent.
- reference: PMID:24186945
reference_title: "Respiratory disease mortality among US coal miners; results after 37 years of follow-up."
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
snippet: "Our findings support previous studies showing that exposure to coal mine dust and respirable silica leads to increased mortality from malignant and non-malignant respiratory diseases even in the absence of smoking."
explanation: >-
Indirect: establishes dust-attributable non-malignant respiratory disease
independent of smoking, from which the dust rather than smoking origin of
the emphysema follows. It reports mortality, not morphology.
- name: Restrictive ventilatory defect
category: Respiratory
description: >-
Reduced lung volumes from conglomerate fibrosis, typically combined with an
obstructive component in advanced disease.
phenotype_term:
preferred_term: Restrictive ventilatory defect
term:
id: HP:0002091
label: Restrictive ventilatory defect
evidence:
- reference: PMID:11952275
reference_title: "Pulmonary function impairment in pneumoconiotic patients with progressive massive fibrosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The major pattern of impairment for miners with PMF was obstructive, but there was an increasing trend for restrictive impairment for higher radiological categories."
explanation: >-
Distinguishes the restrictive from the obstructive pattern and ties the
restrictive component to advancing radiographic category, which the
biomarker correlation cited elsewhere cannot do.
- reference: PMID:35032040
reference_title: "Respiratory health of American Indian and Alaska Native coal miners participating in the Coal Workers' Health Surveillance Program, 2014-2019."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Lung function abnormalities were seen in 9.0% with primarily restrictive patterns."
explanation: >-
Surveillance spirometry showing the restrictive pattern predominating in a
screened miner population.
- name: Airway obstruction
category: Respiratory
description: >-
Airflow limitation from small-airway disease and focal emphysema. Coal mine
dust causes chronic obstructive pulmonary disease independently of the
fibrotic pneumoconiosis, which is why surveillance spirometry was added to
radiographic screening.
phenotype_term:
preferred_term: Airway obstruction
term:
id: HP:0006536
label: Airway obstruction
evidence:
- reference: PMID:31302880
reference_title: "Current Review of Pneumoconiosis Among US Coal Miners."
supports: SUPPORT
evidence_source: OTHER
snippet: "since coal mine dust can cause chronic obstructive pulmonary disease (COPD), which is not reliably detected by chest radiography"
explanation: >-
States that coal mine dust causes obstructive disease and that radiography
misses it, the rationale for adding spirometry to surveillance.
- name: Hypoxemia
category: Respiratory
description: >-
Low arterial oxygen from ventilation-perfusion mismatch and destroyed gas
exchange surface in advanced disease; the usual indication for supplemental
oxygen.
phenotype_term:
preferred_term: Hypoxemia
term:
id: HP:0012418
label: Hypoxemia
evidence:
- reference: PMID:39620857
reference_title: "Outcomes of Lung Transplantation in Coal Workers Pneumoconiosis: Analysis of UNOS Database."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "CWP group was noted to have higher mean pulmonary artery pressures, LAS, need for prolonged intubation and extracorporeal membrane oxygenation (ECMO) at 72 h"
explanation: >-
Documents severe gas-exchange failure in end-stage CWP, to the point of
requiring extracorporeal support around transplantation.
- name: Elevated pulmonary artery pressure
category: Cardiovascular
description: >-
Pulmonary hypertension arising from chronic hypoxic vasoconstriction and
destruction of the pulmonary vascular bed by fibrosis and emphysema. Measured
to be higher in CWP transplant candidates than in other transplant
indications.
phenotype_term:
preferred_term: Elevated pulmonary artery pressure
term:
id: HP:0004890
label: Elevated pulmonary artery pressure
sequelae:
- target: Cor pulmonale
description: >-
Sustained pressure overload of the right ventricle progresses to right
heart failure.
evidence:
- reference: PMID:39620857
reference_title: "Outcomes of Lung Transplantation in Coal Workers Pneumoconiosis: Analysis of UNOS Database."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "CWP group was noted to have higher mean pulmonary artery pressures"
explanation: >-
Direct measurement of elevated mean pulmonary artery pressure in CWP
patients relative to other lung transplant recipients.
- name: Cor pulmonale
category: Cardiovascular
description: >-
Right ventricular failure secondary to sustained pulmonary hypertension, the
terminal cardiovascular consequence of advanced complicated CWP.
phenotype_term:
preferred_term: Cor pulmonale
term:
id: HP:0001648
label: Cor pulmonale
evidence:
- reference: PMID:39620857
reference_title: "Outcomes of Lung Transplantation in Coal Workers Pneumoconiosis: Analysis of UNOS Database."
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
snippet: "CWP group was noted to have higher mean pulmonary artery pressures"
explanation: >-
Indirect: the paper measures the pulmonary hypertension that causes cor
pulmonale rather than right ventricular failure itself, so the cor
pulmonale claim follows by the standard inference from sustained elevated
pulmonary artery pressure and is not asserted by the quote.
environmental:
- name: Occupational inhalation of respirable coal mine dust
description: >-
Cumulative inhalation of respirable coal mine dust during underground or
surface coal mining is the necessary cause of CWP. Classic risk work is
underground extraction, with roof bolting and continuous-miner operation
among the dustiest tasks; contemporary thin-seam mining raises the silica
fraction of the dust because accessing the seam requires cutting
silica-bearing rock.
exposure_term:
preferred_term: exposure to respirable coal mine dust
term:
id: ECTO:7000005
label: exposure to coal dust
exposure_classifications:
hazard_agent_type:
- classification_value: CHEMICAL
notes: >-
Coal mine dust is a mineral dust, classified as a chemical agent in the
occupational-hygiene scheme (ILO section 1.1), not as a physical agent.
exposure_route:
- classification_value: INHALATION
notes: >-
Only the respirable fraction reaching the terminal bronchioles and
alveoli is pathogenic; the route is what defines the exposure.
exposure_duration:
- classification_value: CHRONIC
notes: >-
ATSDR chronic duration (365 days and longer). Classic CWP follows one to
several decades of underground work; the rapidly progressive form
compresses this but is still a multi-year exposure, not an intermediate
or acute one.
ghs_health_hazard_class:
- classification_value: STOT_REPEATED_EXPOSURE
notes: >-
Specific target organ toxicity from repeated exposure — a non-lethal,
organ-specific effect (lung) accumulating over prolonged exposure rather
than an acute toxic response.
exposome_domain:
- classification_value: SPECIFIC_EXTERNAL
notes: >-
An identifiable individual-level occupational agent, in Wild's specific
external domain rather than the general external environment.
notes: >-
No iarc_carcinogen_group is recorded. IARC evaluated coal dust in Monographs
volume 68 and placed it in Group 3 (not classifiable as to carcinogenicity to
humans); the schema's IARCCarcinogenGroupEnum was checked and does admit
GROUP_3, so this omission is a judgement rather than a schema limit — the
Group 3 listing is for coal dust as an agent, while the exposure curated here
is coal *mine* dust, a mixture whose silica fraction carries its own
classification. Crystalline silica's Group 1 listing belongs to the Silicosis
entry's exposure, not to this one. The cohort association between coal mine
dust and lung cancer mortality is instead curated as evidence, on the
mortality items below.
evidence:
- reference: PMID:41411198
reference_title: "Coal Workers' Pneumoconiosis-Associated Deaths - United States, 2020-2023."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Among workers employed in the mining industry, the highest PMR was among underground mining machine operators (164.6)."
explanation: >-
Identifies underground mining machine operation as the highest-risk task
by proportionate mortality, grounding the occupational specificity of the
exposure.
- reference: PMID:31302880
reference_title: "Current Review of Pneumoconiosis Among US Coal Miners."
supports: SUPPORT
evidence_source: OTHER
snippet: "Contributing factors may include mining of thin coal seams or cutting rock to access coal, which may expose miners to coal mine dust with a higher content of silica and silicates than in the past."
explanation: >-
Sources the thin-seam mechanism by which contemporary coal mine dust
carries more silica than historical dust.
- reference: PMID:24186945
reference_title: "Respiratory disease mortality among US coal miners; results after 37 years of follow-up."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We saw a significant relationship between coal mine dust exposure and lung cancer mortality (HR=1.70; 95% CI 1.02 to 2.83) but not with respirable silica (HR=1.05; 95% CI 0.90 to 1.23)."
explanation: >-
The lung-cancer association this exposure's notes refer to, with the effect
attaching to coal mine dust rather than to its respirable silica fraction.
Curated as evidence on the exposure rather than as a hazard classification.
- reference: PMID:36635098
reference_title: "Increased odds of mortality from non-malignant respiratory disease and lung cancer are highest among US coal miners born after 1939."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "US coal miners have excess mortality from NMRD and lung cancer compared with total US and Appalachian populations. Mortality is highest in the most recent birth cohorts, perhaps reflecting increased rates of severe pneumoconiosis."
explanation: >-
Independent evidence that both malignant and non-malignant respiratory
mortality is concentrated in later birth cohorts, consistent with the
contemporary exposure shift this entry models.
influences_mechanisms:
- target: Respirable Coal Mine Dust Deposition and Retention
environmental_effect: TRIGGERS
causal_link_type: DIRECT
description: >-
Coal extraction liberates dust in the respirable size range, which is the
fraction that reaches the terminal bronchioles and alveoli to be deposited
and retained.
evidence:
- reference: PMID:41411198
reference_title: "Coal Workers' Pneumoconiosis-Associated Deaths - United States, 2020-2023."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Coal workers' pneumoconiosis (CWP) is a preventable, progressive occupational lung disease caused by inhaling respirable coal mine dust, a complex mixture commonly containing coal, crystalline silica, and other silicate minerals."
explanation: >-
Ties the occupational activity directly to inhalation of the respirable
dust that the deposition node represents.
- target: Silica-Enriched Dust Burden
environmental_effect: EXACERBATES
causal_link_type: DIRECT
description: >-
Cutting silica-bearing rock strata to reach thin coal seams raises the
crystalline-silica content of the generated dust, which is what shifts the
retained burden toward the more fibrogenic silica-enriched form.
evidence:
- reference: PMID:31302880
reference_title: "Current Review of Pneumoconiosis Among US Coal Miners."
supports: SUPPORT
evidence_source: OTHER
snippet: "Contributing factors may include mining of thin coal seams or cutting rock to access coal, which may expose miners to coal mine dust with a higher content of silica and silicates than in the past."
explanation: >-
States the specific mining practice that raises the silica fraction of
the dust, which is the edge this link asserts.
- name: Cigarette smoking
description: >-
Smoking does not cause CWP and is not required for it — the excess
respiratory mortality of coal miners is present in never-smokers. It is
curated here because it compounds the obstructive component and overall
respiratory morbidity, and smoking cessation is a core management step.
exposure_term:
preferred_term: exposure to cigarette smoking
term:
id: ECTO:0100003
label: exposure to cigarette smoking
review_notes: >-
Bound and pathograph-linked as an explicitly non-causal modifier. An earlier
revision left both the exposure_term and the mechanism link off, reasoning
that binding a tobacco term would imply smoking is etiologic for CWP. That
reasoning does not survive contact with the schema: environmental_effect
exists to separate TRIGGERS from MODULATES, and only TRIGGERS and EXACERBATES
count as causal for compliance scoring. MODULATES states the intended claim
machine-readably instead of burying it in prose.
evidence:
- reference: PMID:24186945
reference_title: "Respiratory disease mortality among US coal miners; results after 37 years of follow-up."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Our findings support previous studies showing that exposure to coal mine dust and respirable silica leads to increased mortality from malignant and non-malignant respiratory diseases even in the absence of smoking."
explanation: >-
Establishes that the dust effect is independent of smoking, which is the
reason smoking is curated here as a compounding factor rather than a cause.
influences_mechanisms:
- target: Impaired Gas Exchange and Mixed Ventilatory Defect
environmental_effect: MODULATES
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
description: >-
Smoking worsens measured lung function in miners who already have
progressive massive fibrosis, on top of the dust-driven impairment, without
being required for it. MODULATES rather than EXACERBATES because the
cohort evidence puts the excess respiratory mortality in never-smokers,
so the interaction is additive burden rather than a demonstrated
amplification of the dust mechanism.
evidence:
- reference: PMID:11952275
reference_title: "Pulmonary function impairment in pneumoconiotic patients with progressive massive fibrosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Smoking miners had even lower FEV1/FVC and DLCO than did their non-smoking counterparts."
explanation: >-
Measures worse airflow obstruction and diffusing capacity in smoking
miners with progressive massive fibrosis, the additive functional effect
this link asserts.
- reference: PMID:11952275
reference_title: "Pulmonary function impairment in pneumoconiotic patients with progressive massive fibrosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The loss of lung function cannot be accounted for by different smoking habits."
explanation: >-
The same study's conclusion that smoking does not explain the impairment,
which is why this link is MODULATES and not a causal edge.
genetic:
- name: TNF
gene_term:
preferred_term: TNF
term:
id: hgnc:11892
label: TNF
association: >-
Host susceptibility modifier. The TNF-alpha promoter polymorphisms -308 and
-238 are associated with CWP risk in meta-analysis of candidate-gene
case-control studies, chiefly in Chinese coal-miner cohorts. These are common
regulatory variants that amplify the TNF-alpha-driven inflammatory response
to retained dust; they modify risk and are neither necessary nor sufficient
without the exposure.
relationship_type: SUSCEPTIBILITY
variant_origin: GERMLINE
evidence:
- reference: PMID:39578762
reference_title: "Candidate gene polymorphisms associated with silicosis and coal workers' pneumoconiosis: a systematic review and meta-analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The analysis revealed that allele A of TNFα-308, allele A of TNFα-238, and allele C of IL-1RA + 2018 were identified as risk factors for the development of diseases."
explanation: >-
Meta-analytic association of both TNF-alpha promoter alleles with disease
risk across the pooled candidate-gene literature.
- reference: PMID:39578762
reference_title: "Candidate gene polymorphisms associated with silicosis and coal workers' pneumoconiosis: a systematic review and meta-analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Despite similar exposure levels, individuals exhibit varying responses."
explanation: >-
States the observation that motivates a host-susceptibility layer at all:
equal dust exposure does not produce equal disease.
notes: >-
The meta-analysis pools silicosis and CWP studies rather than reporting CWP
separately, so the association is not CWP-specific. It is curated as a
susceptibility modifier on that basis and not as a CWP-only effect estimate.
- name: TGFB1
gene_term:
preferred_term: TGFB1
term:
id: hgnc:11766
label: TGFB1
association: >-
Host susceptibility modifier acting on the central profibrotic pathway. In a
case-control study of 508 CWP patients and 526 exposed-miner controls, the
rs1800470 CC genotype was associated with reduced CWP risk and the
rs11466345 GG genotype with increased risk. TGF-beta1 is the same signal the
Fibroblast Activation node is annotated with, so this locus modifies the rate
of a mechanism the entry already models rather than adding a new one.
relationship_type: SUSCEPTIBILITY
variant_origin: GERMLINE
evidence:
- reference: PMID:23554640
reference_title: "Association of transforming growth factor-β1 gene variants with risk of coal workers' pneumoconiosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Multivariate logistic regression analysis revealed that SNP2 (rs1800470) CC genotype was associated with decreased risk of CWP (OR = 0.50, 95% CI = 0.32-0.78)"
explanation: >-
Reports the protective genotype association with an effect estimate in a
CWP-specific exposed-control design.
- reference: PMID:23554640
reference_title: "Association of transforming growth factor-β1 gene variants with risk of coal workers' pneumoconiosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "the SNP5 (rs11466345) GG genotype was associated with an increased risk of CWP (OR = 2.5, 95%CI = 1.36-4.57)"
explanation: >-
Reports the risk-increasing genotype at the same locus, showing the
modifier acts in both directions.
- name: H19
gene_term:
preferred_term: H19
term:
id: hgnc:4713
label: H19
association: >-
Protective susceptibility modifier. The H19 long noncoding RNA variant
rs2067051 CT/TT genotypes were associated with decreased CWP risk in 703
cases and 705 exposed controls from Chinese coal mines. One of the few
reported protective loci in this disease.
relationship_type: SUSCEPTIBILITY
variant_origin: GERMLINE
evidence:
- reference: PMID:27626436
reference_title: "Polymorphisms in Long Noncoding RNA H19 Contribute to the Protective Effects of Coal Workers' Pneumoconiosis in a Chinese Population."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We found that individuals with the H19 rs2067051 CT/TT genotypes showed a decreased risk of CWP compared with those with the CC genotype (adjusted OR = 0.64, 95%CI = 0.49-0.83, p = 0.001)."
explanation: >-
Reports the protective genotype association and effect estimate in a
CWP case-control study with dust-exposed controls.
notes: >-
Single-population candidate-gene finding in Han Chinese miners without
reported independent replication; treat the effect size as provisional. The
same caveat applies to the wider CWP susceptibility literature, which is
dominated by Chinese candidate-gene case-control studies and has no
genome-wide-significant locus.
prevalence:
- population: US underground coal miners with 25 or more years of tenure
measure_type: POINT_PREVALENCE
prevalence_class: ABOVE_1_IN_1000
rate_per_100000: 10000.0
notes: >-
Radiographic CWP (ILO profusion 1/0 or greater, or a large opacity) in the
NIOSH Coal Workers' Health Surveillance Program, 1970-2017. Reported as
"exceeds 10%", so the normalized rate is a floor rather than a point
estimate.
evidence:
- reference: PMID:30024799
reference_title: "Continued Increase in Prevalence of Coal Workers' Pneumoconiosis in the United States, 1970-2017."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Following a low point in the late 1990s, the national prevalence of CWP in miners with 25 years or more of tenure now exceeds 10%."
explanation: >-
Source for the national long-tenure prevalence figure and for the fact
that it is rising from a late-1990s nadir.
- population: Central Appalachian (Kentucky, Virginia, West Virginia) long-tenured coal miners
measure_type: POINT_PREVALENCE
prevalence_class: ABOVE_1_IN_1000
rate_per_100000: 20600.0
notes: >-
20.6% of long-tenured central Appalachian miners, roughly double the national
figure for the same tenure band. This regional concentration is the core
epidemiologic signal of the CWP resurgence.
evidence:
- reference: PMID:30024799
reference_title: "Continued Increase in Prevalence of Coal Workers' Pneumoconiosis in the United States, 1970-2017."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "In central Appalachia (Kentucky, Virginia, West Virginia), 20.6% of long-tenured miners have CWP."
explanation: >-
Direct source for the central Appalachian prevalence figure and the states
it covers.
- population: Central Appalachian coal miners with 25 or more years of tenure (PMF)
measure_type: POINT_PREVALENCE
prevalence_class: ABOVE_1_IN_1000
rate_per_100000: 3200.0
notes: >-
Progressive massive fibrosis specifically, risen from 0.33% to 3.2% in
long-tenured central Appalachian miners — an order-of-magnitude increase in
the disabling form.
evidence:
- reference: PMID:35353671
reference_title: "Pathology and Mineralogy Demonstrate Respirable Crystalline Silica Is a Major Cause of Severe Pneumoconiosis in U.S. Coal Miners."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "the prevalence of PMF has increased from 0.33% to 3.2% in miners with 25 years or more of tenure"
explanation: >-
Source for both the current PMF prevalence and the magnitude of its
increase in this population.
biochemical:
- name: Serum Krebs von den Lungen-6 (KL-6)
presence: INCREASED
biomarker_term:
preferred_term: Krebs von den Lungen-6
term:
id: NCIT:C154724
label: Krebs von den Lungen-6 Measurement
readouts:
- target: Alveolar Epithelial Injury and Epithelial-Mesenchymal Transition
relationship: READOUT_OF
direction: POSITIVE
endpoint_context: DIAGNOSTIC
interpretation: >-
KL-6 is shed by injured and regenerating alveolar type II cells, so rising
serum concentration reports the alveolar epithelial injury node rather
than the fibrotic mass burden directly.
evidence:
- reference: PMID:37284491
reference_title: "Serum Osteopontin, KL-6, and Syndecan-4 as Potential Biomarkers in the Diagnosis of Coal Workers' Pneumoconiosis: A Case-Control Study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Compared with HCs, patients with higher OPN, KL-6, Syndecan-4 and Gremlin-1 had higher risk for CWP."
explanation: >-
Establishes the positive direction of the marker with respect to
disease, the claim this readout link makes.
notes: >-
A mucin-like glycoprotein released by injured and regenerating alveolar type
II cells, elevated in CWP and rising stepwise from healthy controls through
dust-exposed workers to diagnosed patients. Investigational rather than
established practice; CWP is still diagnosed by exposure history plus
radiography.
evidence:
- reference: PMID:37284491
reference_title: "Serum Osteopontin, KL-6, and Syndecan-4 as Potential Biomarkers in the Diagnosis of Coal Workers' Pneumoconiosis: A Case-Control Study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The pulmonary function parameters decreased sequentially, and the serum OPN, KL-6, Syndecan-4 and Gremlin-1 concentrations were increased sequentially among the HC, DEW and CWP groups."
explanation: >-
Shows the stepwise rise in serum KL-6 across exposure and disease groups,
alongside falling pulmonary function.
- name: Serum osteopontin
presence: INCREASED
biomarker_term:
preferred_term: osteopontin
term:
id: NCIT:C124349
label: Osteopontin Measurement
readouts:
- target: Sustained Inflammatory Cell Recruitment and Amplification
relationship: READOUT_OF
direction: POSITIVE
endpoint_context: DIAGNOSTIC
interpretation: >-
Osteopontin is a macrophage-associated matricellular protein, so serum
concentration tracks the sustained inflammatory recruitment node rather
than a specific matrix compartment.
evidence:
- reference: PMID:37284491
reference_title: "Serum Osteopontin, KL-6, and Syndecan-4 as Potential Biomarkers in the Diagnosis of Coal Workers' Pneumoconiosis: A Case-Control Study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The pulmonary function parameters decreased sequentially, and the serum OPN, KL-6, Syndecan-4 and Gremlin-1 concentrations were increased sequentially among the HC, DEW and CWP groups."
explanation: >-
Shows serum osteopontin rising stepwise with exposure and disease
status, the graded positive relationship this readout asserts.
notes: >-
A matricellular protein linked to macrophage activation and fibrogenesis,
elevated in CWP and part of a three-marker panel with KL-6 and syndecan-4
that improves discrimination of patients from dust-exposed workers.
evidence:
- reference: PMID:37284491
reference_title: "Serum Osteopontin, KL-6, and Syndecan-4 as Potential Biomarkers in the Diagnosis of Coal Workers' Pneumoconiosis: A Case-Control Study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The combination of OPN, KL-6, and Syndecan-4 can improve the diagnostic sensitivity and specificity of CWP patients differentiated from HCs or DEWs."
explanation: >-
Reports the panel's incremental diagnostic value over single markers, the
basis for curating these together.
- name: Serum syndecan-4
presence: INCREASED
biomarker_term:
preferred_term: syndecan-4
readouts:
- target: Peribronchiolar Collagen Deposition and Coal Macule Formation
relationship: READOUT_OF
direction: POSITIVE
endpoint_context: DIAGNOSTIC
interpretation: >-
Syndecan-4 is a cell-surface heparan sulfate proteoglycan involved in
matrix assembly, so serum concentration is read here against the matrix
deposition node rather than against the inflammatory compartment.
evidence:
- reference: PMID:37284491
reference_title: "Serum Osteopontin, KL-6, and Syndecan-4 as Potential Biomarkers in the Diagnosis of Coal Workers' Pneumoconiosis: A Case-Control Study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The pulmonary function parameters decreased sequentially, and the serum OPN, KL-6, Syndecan-4 and Gremlin-1 concentrations were increased sequentially among the HC, DEW and CWP groups."
explanation: >-
Shows the graded positive relationship across healthy controls,
dust-exposed workers and CWP patients that this readout asserts.
notes: >-
No ontology term is bound. NCIT has no syndecan-4 measurement concept, and
binding a broader proteoglycan term would name a different analyte — the
"no term beats a bad one" rule. Part of the three-marker panel below.
evidence:
- reference: PMID:37284491
reference_title: "Serum Osteopontin, KL-6, and Syndecan-4 as Potential Biomarkers in the Diagnosis of Coal Workers' Pneumoconiosis: A Case-Control Study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The combination of OPN, KL-6, and Syndecan-4 can improve the diagnostic sensitivity and specificity of CWP patients differentiated from HCs or DEWs."
explanation: >-
Establishes syndecan-4 as the third member of the panel whose combination
outperforms any single marker.
- name: Serum gremlin-1
presence: INCREASED
biomarker_term:
preferred_term: gremlin-1
readouts:
- target: Fibroblast Activation and Myofibroblast Differentiation
relationship: READOUT_OF
direction: POSITIVE
endpoint_context: DIAGNOSTIC
interpretation: >-
Gremlin-1 is a BMP antagonist that de-represses TGF-beta-driven
fibrogenesis, so it is read against the mesenchymal activation node.
evidence:
- reference: PMID:37284491
reference_title: "Serum Osteopontin, KL-6, and Syndecan-4 as Potential Biomarkers in the Diagnosis of Coal Workers' Pneumoconiosis: A Case-Control Study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The pulmonary function parameters decreased sequentially, and the serum OPN, KL-6, Syndecan-4 and Gremlin-1 concentrations were increased sequentially among the HC, DEW and CWP groups."
explanation: >-
Shows gremlin-1 rising stepwise with exposure and disease status, the
graded relationship this readout asserts.
notes: >-
No ontology term is bound; NCIT has no gremlin-1 measurement concept.
Measured in the same 400-subject series as the other three markers but not
part of the validated three-marker diagnostic combination.
evidence:
- reference: PMID:37284491
reference_title: "Serum Osteopontin, KL-6, and Syndecan-4 as Potential Biomarkers in the Diagnosis of Coal Workers' Pneumoconiosis: A Case-Control Study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Compared with HCs, patients with higher OPN, KL-6, Syndecan-4 and Gremlin-1 had higher risk for CWP."
explanation: >-
Associates higher gremlin-1 with CWP risk in the case-control series.
treatments:
- name: Exposure Cessation and Dust Reduction
description: >-
Removal from further dust exposure — through the Part 90 transfer right,
engineering controls, or leaving the work — is the only intervention that
changes the disease trajectory in early CWP. It halts accrual of new dust
burden; it does not clear retained dust, and it does not reliably stop PMF,
which can progress after exposure ends.
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: occupational exposure cessation
term:
id: NCIT:C49236
label: Therapeutic Procedure
target_mechanisms:
- target: Respirable Coal Mine Dust Deposition and Retention
description: >-
Ending exposure stops further deposition and retention of respirable dust,
capping the cumulative burden that drives every downstream step.
evidence:
- reference: PMID:36972614
reference_title: "Pathology and Mineralogy of the Pneumoconioses."
supports: SUPPORT
evidence_source: OTHER
snippet: "Most pneumoconioses are irreversible and incurable, but disease progression can be mitigated by removal from or reduction in further exposure."
explanation: >-
States both halves of this treatment's claim: the disease is not
reversible, and exposure reduction is what mitigates progression.
- reference: PMID:41411198
reference_title: "Coal Workers' Pneumoconiosis-Associated Deaths - United States, 2020-2023."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Disease progression can occur after cessation of exposure"
explanation: >-
Sources the limit on this treatment stated in its description: stopping
exposure caps the dust burden but does not reliably stop established
disease from advancing.
- name: Supportive Respiratory Care
description: >-
Vaccination against influenza and pneumococcus, prompt treatment of
respiratory infection, mycobacterial surveillance given impaired local lung
defences, and smoking cessation. Standard of care and the backbone of
management at every stage, since no disease-modifying drug exists.
therapeutic_modality: OTHER
treatment_term:
preferred_term: Supportive Care
term:
id: NCIT:C15747
label: Supportive Care
evidence:
- reference: PMID:36972614
reference_title: "Pathology and Mineralogy of the Pneumoconioses."
supports: SUPPORT
evidence_source: OTHER
snippet: "Many pneumoconioses are irreversible and develop due to excessive cumulative respirable dust inhalation."
explanation: >-
Establishes the irreversibility that makes supportive rather than curative
management the standard of care.
- name: Pulmonary Rehabilitation
description: >-
Structured exercise and education to maintain functional capacity and
activities of daily living in miners with established functional impairment.
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: Pulmonary Rehabilitation
term:
id: NCIT:C157966
label: Pulmonary Rehabilitation
target_mechanisms:
- target: Impaired Gas Exchange and Mixed Ventilatory Defect
description: >-
Targets the functional consequences of impaired gas exchange and mixed
ventilatory defect rather than the fibrotic lesion itself.
evidence:
- reference: PMID:37284491
reference_title: "Serum Osteopontin, KL-6, and Syndecan-4 as Potential Biomarkers in the Diagnosis of Coal Workers' Pneumoconiosis: A Case-Control Study."
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
snippet: "Because the disease is progressive and incurable, early diagnosis or early prevention is especially important to control this disease."
explanation: >-
Indirect: the quote establishes that CWP is progressive and incurable —
the reason management is functional rather than curative — but does not
itself evaluate pulmonary rehabilitation.
- name: Long-Term Oxygen Therapy
description: >-
Supplemental oxygen for chronic hypoxemia in advanced disease, and to
mitigate the hypoxic pulmonary vasoconstriction that drives pulmonary
hypertension and cor pulmonale.
therapeutic_modality: OTHER
treatment_term:
preferred_term: Oxygen Therapy
term:
id: NCIT:C94624
label: Oxygen Therapy
target_mechanisms:
- target: Impaired Gas Exchange and Mixed Ventilatory Defect
description: >-
Compensates for the failed gas exchange surface; it does not alter the
fibrotic or emphysematous lesion producing it.
evidence:
- reference: PMID:39620857
reference_title: "Outcomes of Lung Transplantation in Coal Workers Pneumoconiosis: Analysis of UNOS Database."
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
snippet: "CWP group was noted to have higher mean pulmonary artery pressures, LAS, need for prolonged intubation and extracorporeal membrane oxygenation (ECMO) at 72 h"
explanation: >-
Indirect: documents the severity of oxygenation failure in advanced CWP
that indicates oxygen support, rather than evaluating long-term oxygen
therapy as an intervention.
- name: Lung Transplantation
description: >-
The only definitive intervention for end-stage CWP with progressive
respiratory failure. Post-transplant graft and patient survival in CWP
recipients are comparable to other indications, so the disease is not itself
a contraindication, though CWP candidates arrive with higher pulmonary artery
pressures and higher allocation scores and have a more demanding
perioperative course.
therapeutic_modality: SURGERY
treatment_term:
preferred_term: Organ Transplantation
term:
id: NCIT:C15289
label: Organ Transplantation
target_mechanisms:
- target: Nodule Coalescence into Progressive Massive Fibrosis
description: >-
Replaces the fibrotic organ outright. It is the only listed treatment that
removes the conglomerate lesion rather than managing its consequences.
evidence:
- reference: PMID:39620857
reference_title: "Outcomes of Lung Transplantation in Coal Workers Pneumoconiosis: Analysis of UNOS Database."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Overall graft survival (Log-rank p = 0.889) and patient survival (Log-rank p = 0.910) were not significantly different between the two groups."
explanation: >-
Registry comparison showing CWP transplant recipients do as well as
recipients transplanted for other indications.
- reference: PMID:39620857
reference_title: "Outcomes of Lung Transplantation in Coal Workers Pneumoconiosis: Analysis of UNOS Database."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Between May 2005 and June 2021, 158 patients underwent LT for CWP."
explanation: >-
Establishes the cohort size behind the survival comparison, so the
equivalence claim is not read off a handful of cases.
- reference: PMID:22360577
reference_title: "Lung transplantation in patients with coal workers' pneumoconiosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "There was no increased risk of perioperative or postoperative complications."
explanation: >-
Independent single-centre series reaching the same conclusion on
perioperative safety.
- name: Antifibrotic Therapy
description: >-
Pirfenidone, an antifibrotic established in idiopathic pulmonary fibrosis, has
been trialled in CWP with pulmonary fibrosis on the reasoning that the
fibroblast-activation step is shared. Investigational, not standard of care —
no antifibrotic is approved for CWP. Nintedanib is discussed in the same
context in the literature but is not listed as a therapeutic_agent here
because no CWP trial or study was found to cite for it.
therapeutic_modality: SMALL_MOLECULE
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: pirfenidone
term:
id: CHEBI:32016
label: pirfenidone
target_mechanisms:
- target: Fibroblast Activation and Myofibroblast Differentiation
description: >-
Both agents act on the fibroblast activation and matrix-deposition step
that this entry models as the central effector of the lesion.
evidence:
- reference: clinicaltrials:NCT04461587
reference_title: "Examination of Pirfenidone (Esbriet®) Therapy in Coal Workers' Pneumoconiosis With Pulmonary Fibrosis Associated With Radiographic and Functional Impairment to Examine the Reduction in Progression of Disease, Reduction of Exacerbation Rates and Possible Reduction of Inflammatory Biomarkers as an Index of Clinical Response."
supports: SUPPORT
evidence_source: OTHER
snippet: "Examination of pirfenidone (Esbriet®) therapy in coal workers' pneumoconiosis (black lung) with pulmonary fibrosis (scarring of the lung)."
explanation: >-
Registration record establishing that pirfenidone has been formally
trialled in CWP with pulmonary fibrosis. A trial record documents that the
question was asked; it is not evidence the therapy works.
clinical_trials:
- name: NCT04461587
phase: PHASE_II
status: COMPLETED
description: >-
Phase II study of pirfenidone in coal workers' pneumoconiosis with pulmonary
fibrosis and radiographic and functional impairment, examining reduction in
disease progression, exacerbation rates, and inflammatory biomarkers.
target_phenotypes:
- preferred_term: Pulmonary fibrosis
term:
id: HP:0002206
label: Pulmonary fibrosis
evidence:
- reference: clinicaltrials:NCT04461587
reference_title: "Examination of Pirfenidone (Esbriet®) Therapy in Coal Workers' Pneumoconiosis With Pulmonary Fibrosis Associated With Radiographic and Functional Impairment to Examine the Reduction in Progression of Disease, Reduction of Exacerbation Rates and Possible Reduction of Inflammatory Biomarkers as an Index of Clinical Response."
supports: SUPPORT
evidence_source: OTHER
snippet: "Examination of pirfenidone (Esbriet®) therapy in coal workers' pneumoconiosis (black lung) with pulmonary fibrosis (scarring of the lung)."
explanation: >-
ClinicalTrials.gov record establishing the trial's population,
intervention, and target condition.
differential_diagnoses:
- name: Caplan Syndrome
disease_term:
preferred_term: Caplan syndrome
term:
id: MONDO:0005690
label: Caplan syndrome
description: >-
Rheumatoid pneumoconiosis: well-defined peripheral pulmonary nodules with
necrobiotic centres retaining mineral dust, arising in a dust-exposed worker
who also has rheumatoid arthritis. First described in Welsh coal miners, and
a genuine consideration in any miner presenting with nodules.
distinguishing_features:
- Coexisting rheumatoid arthritis, which ordinary CWP does not require
- Peripheral, well-defined nodules rather than the upper-zone rounded opacities of simple CWP
- Necrobiotic nodule centre retaining mineral dust
- Nodules may appear before, at, or years after the arthritis is diagnosed
evidence:
- reference: PMID:34027516
reference_title: "Caplan's Syndrome with a twist."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Classically, they form peripheral well-defined pulmonary nodules with characteristic silica retained in the necrobiotic center."
explanation: >-
Describes the nodule morphology and retained mineral dust that separate
Caplan syndrome from ordinary rheumatoid lung nodules and from the coal
macule.
- reference: PMID:34027516
reference_title: "Caplan's Syndrome with a twist."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Caplan's syndrome also known as rheumatoid pneumoconiosis is a disease entity that is seen in patients with rheumatoid arthritis (RA) exposed to chronic silica and inorganic dust"
explanation: >-
States the exposure range — chronic silica and inorganic dust generally,
not coal specifically — which is the nosological point behind curating this
as a differential rather than a coal-dust subtype.
notes: >-
Curated as a differential rather than as a CWP subtype because MONDO makes it
a sibling, not a child: MONDO:0005690 is a direct subclass of MONDO:0015926
pneumoconiosis, the parent of MONDO:0006654 anthracosis, and it arises on
silicosis and asbestosis as readily as on coal dust. Recording it under
has_subtypes would both misstate that nosology and, because subtype terms
count as curated, retire MONDO:0005690 from the curation queue as though this
entry covered it.
The cited case had silica and asbestos exposure rather than coal mining, so
it is used for the generic rheumatoid-pneumoconiosis lesion and not as a
coal-miner case. A coal-miner Caplan citation would be a worthwhile addition;
none was found in the cached reference set.
diagnosis:
- name: Occupational exposure history with ILO-classified chest radiography
diagnosis_term:
preferred_term: Chest Radiography
term:
id: NCIT:C38103
label: Chest Radiography
description: >-
CWP is diagnosed clinically, not histologically: a compatible coal mine dust
exposure history plus a characteristic chest radiograph classified under the
ILO International Classification of Radiographs of Pneumoconioses, read by a
NIOSH-certified B Reader. Profusion of small opacities is graded 0-3 with
size categories p/q/r, and large opacities A/B/C define the complicated form.
Tissue sampling is reserved for atypical presentations or a separate
indication such as suspected malignancy. Certification matters measurably —
non-certified readers over-read both presence and severity.
evidence:
- reference: PMID:36972614
reference_title: "Pathology and Mineralogy of the Pneumoconioses."
supports: SUPPORT
evidence_source: OTHER
snippet: "Diagnosis of silicosis, coal workers’ pneumoconiosis, or asbestosis may be made based on a suggestive occupational history and typical chest imaging without the need for tissue sampling."
explanation: >-
States the two-part diagnostic basis this entry uses and that biopsy is
not required.
- reference: PMID:36972614
reference_title: "Pathology and Mineralogy of the Pneumoconioses."
supports: SUPPORT
evidence_source: OTHER
snippet: "A chest radiograph classified using the International Labor Office (ILO) system has been the mainstay for medical surveillance of pneumoconioses in dusty trades."
explanation: >-
Sources the ILO classification as the standard instrument, which the
subtype definitions in this entry are stated in terms of.
- reference: PMID:31302880
reference_title: "Current Review of Pneumoconiosis Among US Coal Miners."
supports: SUPPORT
evidence_source: OTHER
snippet: "Certified B Readers are physicians who have successfully passed the certification examination, demonstrating competence with the ILO system."
explanation: >-
Sources the B Reader certification that the surveillance program depends
on for consistent classification.
- reference: PMID:31302880
reference_title: "Current Review of Pneumoconiosis Among US Coal Miners."
supports: SUPPORT
evidence_source: OTHER
snippet: "Specifically, compared to B Readers, physicians who have not passed the certification examination tend to over-read for disease presence and severity."
explanation: >-
Quantifies why the certification is a diagnostic requirement rather than a
formality — uncertified reading biases both presence and severity upward.
notes: >-
Radiography does not distinguish between the coal-dust-induced interstitial
lung diseases, so a surveillance "case of CWP" is an opacity-based
definition rather than a claim about which lesion is present. Genetic testing
has no diagnostic role; the susceptibility loci curated in `genetic:` are
research findings.
imaging_findings:
- name: Rounded small opacities on chest radiography
modality: XRAY
description: >-
Small rounded opacities, graded p (up to 1.5 mm), q (1.5-3 mm) and r (3-10
mm) by the ILO system, corresponding pathologically to coal macules and
nodules. Irregular opacities in the same films correspond instead to
interstitial fibrosis, so opacity shape carries lesion information.
phenotype_term:
preferred_term: Pulmonary nodule
term:
id: HP:0033608
label: Pulmonary nodule
diagnostic: true
evidence:
- reference: PMID:36972614
reference_title: "Pathology and Mineralogy of the Pneumoconioses."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
A chest radiograph classified using the International Labor Office (ILO) system has been the
mainstay for medical surveillance of pneumoconioses in dusty trades. ... Coal mine dust lung
disease (CMDLD), or black lung, is a group of lung conditions caused by exposure to coal mine
dust, including emphysema, chronic obstructive pulmonary disease, dust-related diffuse
fibrosis, and coal worker’s pneumoconiosis (CWP). CWP can be diagnosed by finding rounded or
irregular linear opacities on chest imaging in association with a compatible exposure history.
Pathologic studies have shown that rounded opacities on chest imaging correspond to coal
macules and coal nodules, and irregular opacities to interstitial fibrosis.
explanation: >-
Restores the plain-radiograph/ILO context and coal-workers' pneumoconiosis diagnostic setting
before the opacity-to-pathology mapping. The selected passage does not give p/q/r millimeter
boundaries.
- name: Nodules on high-resolution CT not visible on plain radiography
modality: CT
description: >-
HRCT detects parenchymal nodules in miners whose plain films are classified
ILO category 0/0, so radiographic surveillance under-calls early disease.
This is a sensitivity gap in the diagnostic standard rather than a competing
diagnostic criterion.
evidence:
- reference: PMID:8404184
reference_title: "High-resolution CT in simple coal workers' pneumoconiosis. Lack of correlation with pulmonary function tests and arterial blood gas values."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "By HRCT, nodules were identified in 12 miners; 4 of 9 were classified as category 0/0 CWP"
explanation: >-
Directly measures the under-detection: nodules on HRCT in miners the ILO
film classification called normal.
histopathology:
- name: Coal macule
description: >-
Black pigment deposited around the walls of respiratory bronchioles and
alveolar ducts, comprising dust-laden macrophages with reticulin and
collagen. The earliest lesion of CWP and, with the coal nodule, what
pathologically defines the simple form.
diagnostic: true
evidence:
- reference: PMID:36972614
reference_title: "Pathology and Mineralogy of the Pneumoconioses."
supports: SUPPORT
evidence_source: OTHER
snippet: "The coal macule is the earliest lesion to form and consists of black pigment deposited around walls of respiratory bronchioles and alveolar ducts."
explanation: >-
Defines the lesion and fixes its anatomical location at the respiratory
bronchiole, matching the pathophysiology node that builds it.
- reference: PMID:36972614
reference_title: "Pathology and Mineralogy of the Pneumoconioses."
supports: SUPPORT
evidence_source: OTHER
snippet: "Simple CWP is pathologically defined by the presence of coal macules and nodules."
explanation: >-
Makes the macule the defining histologic criterion for the simple subtype
curated in has_subtypes.
- name: Mineral dust alveolar proteinosis
description: >-
Accumulation of surfactant-like material in alveoli, a marker of very heavy
dust burden. Substantially more common in contemporary US miners than in
their historical counterparts, tracking the same silica-enriched exposure
shift as silica-type PMF.
evidence:
- reference: PMID:35353671
reference_title: "Pathology and Mineralogy Demonstrate Respirable Crystalline Silica Is a Major Cause of Severe Pneumoconiosis in U.S. Coal Miners."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Mineral dust alveolar proteinosis was also more common in contemporary miners compared with their historical counterparts (70% vs. 37%; P < 0.01)."
explanation: >-
Quantifies the finding and its historical shift in autopsy material from
US coal miners with progressive massive fibrosis.
discussions:
- discussion_id: emt_human_fidelity
kind: HUMAN_MODEL_MISMATCH
status: OPEN
prompt: >-
Does epithelial-mesenchymal transition in alveolar epithelial cells actually
contribute myofibroblasts to human coal workers' pneumoconiosis, or is the
EMT branch curated here an artifact of the model system it was demonstrated
in?
attaches_to:
- pathophysiology#Alveolar Epithelial Injury and Epithelial-Mesenchymal Transition
- pathophysiology#Fibroblast Activation and Myofibroblast Differentiation
rationale: >-
The entire EMT branch rests on one study, PMID:36581638. Its in vitro arm
used A549 — a lung adenocarcinoma line standing in for alveolar type II
cells — and BEAS-2B, a bronchial line; its in vivo arm gave C57BL/6 mice coal
dust *nanoparticles*, a fraction of, not a substitute for, the respirable
coal mine dust miners inhale. No human CWP tissue evidence supports the
branch.
Two things make this a mismatch rather than a plain gap. The node binds
CL:0002063 pulmonary alveolar type 2 cell and asserts type-II EMT in human
disease on the strength of a carcinoma line's behaviour. And EMT as a source
of myofibroblasts in human lung fibrosis is contested in its own right, not
settled background — lineage-tracing work in other fibrotic lung disease has
repeatedly failed to confirm it. The mechanism is well evidenced in the model;
whether it operates in a miner's lung is the open question.
proposed_experiments:
- experiment_id: emt_lineage_trace_coal_dust
name: Lineage-traced fate mapping of alveolar type II cells in a coal mine dust model
description: >-
Expose alveolar-type-II-lineage-labelled reporter mice to authentic
respirable coal mine dust rather than to a nanoparticle fraction, and score
whether labelled cells appear within fibrotic lesions carrying myofibroblast
markers. Substituting real mine dust for the nanoparticle preparation is the
point of the experiment, not an incidental detail.
would_support:
- pathophysiology#Alveolar Epithelial Injury and Epithelial-Mesenchymal Transition
supporting_outcome:
- >-
Lineage-labelled alveolar type II descendants are found inside coal macules
and fibrotic foci co-expressing alpha-SMA, in proportion to lesion burden.
would_refute:
- pathophysiology#Alveolar Epithelial Injury and Epithelial-Mesenchymal Transition
refuting_outcome:
- >-
Labelled cells remain confined to the epithelium with no alpha-SMA-positive
descendants in lesions, placing the myofibroblast pool entirely with
resident mesenchymal cells.
- experiment_id: emt_marker_human_cwp_tissue
name: EMT marker localization in human CWP lung tissue
description: >-
Apply dual-marker immunohistochemistry for epithelial and mesenchymal
markers to archived human coal miner lung specimens — the National Coal
Workers' Autopsy Study material this entry already cites for PMF typing —
scoring cells at the macule and PMF margins for a transitional phenotype.
would_support:
- pathophysiology#Alveolar Epithelial Injury and Epithelial-Mesenchymal Transition
supporting_outcome:
- >-
Cells co-expressing epithelial and mesenchymal markers are enriched at
lesion margins in miner lung relative to unexposed controls.
would_refute:
- pathophysiology#Alveolar Epithelial Injury and Epithelial-Mesenchymal Transition
refuting_outcome:
- >-
No transitional phenotype is detectable at lesion margins, leaving the EMT
branch unsupported in human tissue.
notes: >-
Recorded rather than resolved by deleting the branch: the model evidence is
real and the branch is the only route by which epithelial injury reaches the
fibroblast pool in this entry. The point is that its translational status is
unestablished, not that it is wrong.
animal_models:
- name: Coal-silica mixed dust mouse model with kinetin mitophagy rescue
species: Mouse
genotype: Wild-type, with PINK1 overexpression and PINK1 knockdown arms
publication: PMID:41894156
description: >-
Coal-silica mixed dust exposure in mice, with pharmacological mitophagy
activation (kinetin) as a rescue arm and PINK1 knockdown to test pathway
dependence. The genetic arms are what make this more than an exposure
model: abolishing the rescue by knocking down PINK1 establishes the
mechanism rather than just the association.
modeled_mechanisms:
- target: Macrophage Mitochondrial Dysfunction and Defective Mitophagy
relationship: RECAPITULATES
fidelity: MODERATE
description: >-
Reproduces the mitochondrial collapse and mitophagy failure in
macrophages after mixed coal-silica dust exposure.
limitations: >-
Mouse macrophages, and a coal-silica mixture whose ratio need not match
any particular mine's respirable dust. No human coal miner tissue
confirmation of the PINK1/Parkin defect exists.
readouts:
- name: Mitochondrial membrane potential and oxidative phosphorylation
target: Macrophage Mitochondrial Dysfunction and Defective Mitophagy
direction: DECREASED
interpretation: >-
Direct functional correlate of the mitochondrial dysfunction node.
evidence:
- reference: PMID:41894156
reference_title: "Activation of Mitophagy by Kinetin Mitigates Coal-Silica Mixed Dust-Induced Pulmonary Fibrosis via Modulating Macrophage Mitochondrial Function in Mice."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "CSD exposure triggered ROS accumulation, mitochondrial membrane potential collapse, and impaired oxidative phosphorylation, leading to reduced adenosine triphosphate synthesis."
explanation: >-
Reports the measurement behind this readout and its direction.
- name: PINK1/Parkin-mediated mitophagy after kinetin treatment
target: Macrophage Mitochondrial Dysfunction and Defective Mitophagy
direction: RESTORED
interpretation: >-
The rescue arm. Restoring mitophagy reverses the downstream inflammation
and fibrosis, which is what makes the node causal rather than
correlative.
evidence:
- reference: PMID:41894156
reference_title: "Activation of Mitophagy by Kinetin Mitigates Coal-Silica Mixed Dust-Induced Pulmonary Fibrosis via Modulating Macrophage Mitochondrial Function in Mice."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "kinetin treatment and PINK1 overexpression restored PINK1/Parkin activation and LC3II-dependent mitophagy, alleviated mitochondrial dysfunction, and suppressed subsequent macrophage inflammation and pulmonary fibrosis."
explanation: >-
Documents the restoration and that it suppressed the downstream
inflammation and fibrosis, the direction this readout records.
- target: Nodule Coalescence into Progressive Massive Fibrosis
relationship: PARTIALLY_RECAPITULATES
fidelity: LOW
description: >-
Produces pulmonary fibrosis after mixed-dust exposure, but on a
months-long murine timescale.
limitations: >-
Murine fibrosis after weeks to months of instilled mixed dust is not the
conglomerate mass lesion that defines human PMF after decades of
inhalation. The model speaks to fibrogenesis, not to mass formation.
evidence:
- reference: PMID:41894156
reference_title: "Activation of Mitophagy by Kinetin Mitigates Coal-Silica Mixed Dust-Induced Pulmonary Fibrosis via Modulating Macrophage Mitochondrial Function in Mice."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Kinetin exerts its antifibrotic effects on CWP by promoting PINK1-mediated mitophagy, improving mitochondrial function, and alleviating macrophage inflammation."
explanation: >-
Establishes a fibrotic endpoint in the model that responds to the
mechanism-directed intervention.
- name: Coal dust particle instillation mouse model with vitamin D rescue
species: Mouse
genotype: Wild-type
publication: PMID:35057792
description: >-
Long-course coal dust particle exposure (nine months) with single-cell
transcriptomic readout and a vitamin D treatment arm. The dust used was
characterized as under 5 microns with under 10% silica, so unlike the model
above this one isolates the coal-predominant exposure.
modeled_mechanisms:
- target: Alveolar and Small-Airway Tissue Injury
relationship: RECAPITULATES
fidelity: MODERATE
description: >-
Reproduces alveolar structural destruction and activation of inflammatory
and cell-death pathways after sustained coal dust exposure.
limitations: >-
Nine months in a mouse compresses what takes one to several decades in a
miner, and instillation bypasses the aerodynamic deposition that
determines where inhaled dust actually lands.
readouts:
- name: Alveolar structure and pulmonary microenvironment integrity
target: Alveolar and Small-Airway Tissue Injury
direction: DECREASED
interpretation: >-
Structural correlate of the tissue injury node in a coal-predominant
exposure.
evidence:
- reference: PMID:35057792
reference_title: "Coal dust exposure triggers heterogeneity of transcriptional profiles in mouse pneumoconiosis and Vitamin D remedies."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Alveolar structure and pulmonary microenvironment were destroyed, inflammatory and death (apoptosis, autophagy, and necrosis) pathways were activated, leading to pneumoconiosis in post 9 months coal dust stimulation."
explanation: >-
Reports the structural destruction and pathway activation behind this
readout, on a stated timescale.
- target: Fibroblast Activation and Myofibroblast Differentiation
relationship: PARTIALLY_RECAPITULATES
fidelity: LOW
description: >-
Reproduces profibrotic signalling and an M2 macrophage population that
tracks fibrosis, with vitamin D reducing both.
limitations: >-
The fibrogenic readout is transcriptional and macrophage-phenotypic rather
than the alpha-SMA-positive myofibroblast this node names, so it supports
the surrounding signalling rather than the effector cell itself. Vitamin D
benefit here is not clinically validated in humans.
evidence:
- reference: PMID:35057792
reference_title: "Coal dust exposure triggers heterogeneity of transcriptional profiles in mouse pneumoconiosis and Vitamin D remedies."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Beclin1, LC3B, LAMP2, TGF-ß, and MLPH were up-regulated induced by CDP, promoting autophagy and pulmonary fibrosis."
explanation: >-
Documents upregulated TGF-beta and a profibrotic program, the signalling
this node is annotated with, in a coal-predominant mouse exposure.
Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.
Create: Coal Workers Pneumoconiosis · 2026-09-03T02:53:25Z · View source
Created kb/disorders/Coal_Workers_Pneumoconiosis.yaml de novo (MONDO:0006654, canonical label "anthracosis"; "coal workers' pneumoconiosis" is an exact MONDO synonym). Duplicate preflight: git grep over origin/main kb/ for MONDO:0006654, "coal worker", "anthracosis", "coal dust" returned only Chronic_Obstructive_Pulmonary_Disease (a coal-dust mention, not a CWP entry); stubs/ had no match; GitHub PR and issue searches across all states returned zero. No claim issue existed. Deep research: claude_code provider only, via `just research-disorder claude_code Coal_Workers_Pneumoconiosis`. Run took 254s over 20 turns and 18 web searches, cost ~$1.22, 57 citations. The report carried no reference_validation or term_validation frontmatter block, so both were retro-fitted with `just validate-research-reference` and `just validate-research-terms`. Reference validation on the report: 31/31 resolved, 0 unresolved, 0 off topic. Nothing was excluded on validation grounds. Term validation on the report found 2 terms named as a different term and 4 worth a second look. Independent OAK checks found MORE wrong bindings than the validator flagged, because the validator only checked 14 of 36 names. Every suggested HPO term was re-derived from OAK rather than copied. Wrong report suggestions, all rejected: HP:0002105 report "Restrictive ventilatory defect" -> HP is Hemoptysis (NOT flagged by the validator; caught by direct OAK lookup). Correct term used: HP:0002091. HP:0009777 report "Rheumatoid nodules" -> HP is Absent thumb. Phenotype dropped. HP:0100750 report "Pulmonary nodule" -> HP is Atelectasis. Correct term used: HP:0033608. HP:0031246 report "Chronic cough" -> HP is Nonproductive cough. Correct term used: HP:0034315. HP:0002092 report "Pulmonary hypertension" -> HP is Pulmonary arterial hypertension, a Group 1 entity; CWP causes Group 3 PH. Bound HP:0004890 Elevated pulmonary artery pressure instead. NCIT:C64582 report "Oxygen" -> NCIT is "Hypopharyngeal Cancer pNX TNM Finding v6 and v7". Bound NCIT:C94624 Oxygen Therapy instead. UBERON:0002185 report "bronchiole" -> UBERON is bronchus; UBERON:0000115 report "lung parenchyma" -> UBERON is lung epithelium. Bound UBERON:0002188 respiratory bronchiole, which is where the coal macule actually forms. Every NCIT treatment term was checked for reachability from NCIT:C25218 before use. Citations: the report cites by URL and PMC id rather than PMID, and its .citations.md sidecar contains only the prompt. 21 PMC ids were converted to PMIDs via the PMC ID Converter API and cited as PMIDs; PubMed searches added further primary sources (NIOSH surveillance, the National Coal Workers' Autopsy Study PMF-typing paper, the 37-year mortality cohort, the UNOS transplant analysis). Content: 4 subtypes (simple, complicated/PMF, rapidly progressive, Caplan syndrome); 13-node pathophysiology chain wired with `downstream` edges from dust deposition through macrophage phagocytosis, ROS, NLRP3/NF-kappaB, inflammatory amplification, EMT and fibroblast activation to the coal macule, focal emphysema, PMF and mixed ventilatory defect; a separate `Silica-Enriched Dust Burden` node carrying the contemporary silica-driven resurgence; 10 phenotypes; 2 environmental entries (coal mine dust with exposure_classifications and two influences_mechanisms links, plus smoking as an explicitly non-causal modifier); 3 susceptibility genes (TNF, TGFB1, H19); 3 prevalence records; 2 biomarkers; 6 treatments; 1 clinical trial (NCT04461587). Five nodes declare conforms_to against fibrotic_response (Tissue Injury, Inflammatory Recruitment and Amplification, Mesenchymal Cell Activation, Excessive ECM Deposition, Architectural Distortion and Organ Dysfunction), matching the Asbestosis pattern. Deliberate omissions, recorded so they are not read as oversights: - No `datasets:` block. `just discover-datasets` returned 13 candidates, all GENE_ONLY via TNF/TGFB1/H19 and none about coal dust or pneumoconiosis (Crohn's disease, macular degeneration, ovarian cancer). A direct GEO search found exactly one plausible series, GSE311671, whose title says "Coal Mine Dust" but whose summary and overall design are a silica suspension murine silicosis model. Including it would have been the Named Entity Confusion failure the dataset-curation guidance warns about, so nothing was added. - No iarc_carcinogen_group on the coal mine dust exposure. Coal mine dust itself has no IARC group this entry is entitled to assert; crystalline silica's Group 1 listing belongs to the Silicosis exposure. The coal-dust/lung-cancer association is curated as cohort evidence instead. - ILO item 2.1.9 (COPD from coal dust) deliberately not claimed: it names a different disease outcome of the same exposure, curated under COPD. - No GeneReviews baseline. PubMed search for "pneumoconiosis GeneReviews[All Fields]" returned 0 hits, as expected for a purely acquired occupational disease. - Most `downstream` edges carry no edge-level evidence. Edge evidence was added only for the 8 edges where a source makes the causal claim itself; the rest were left uncited rather than reusing a node citation to paper over an unsourced edge. Validation run: `just validate` and `just validate-disorders` both pass, 72/72 snippets verified against the cached references. check-entity-refs, check-causal-targets, check-duplicate-keys, check-enum-values, check-qualifier-terms and check-qualifier-terms-online all OK. Whole-KB content gates (snippet-length, title-snippets, folded-hyphens, snippet-grading, environmental-evidence) report no new violations. Compliance 84.7% (Silicosis 79.4%, Chronic Beryllium Disease 79.9%, Asbestosis 88.6%). Page renders; the derived HTML was not committed.
Overview. Coal workers' pneumoconiosis (CWP) — colloquially "black lung disease" — is a preventable, progressive occupational interstitial lung disease caused by chronic inhalation of respirable coal mine dust, a complex heterogeneous mixture of coal, crystalline silica, and other silicate minerals (CDC MMWR, 2025). The disease spectrum runs from asymptomatic anthracosis/anthracofibrosis through simple CWP (discrete pulmonary nodules, typically 1–10 mm, containing coal macules and micronodules) to complicated CWP, also called progressive massive fibrosis (PMF), defined by conglomerate fibrotic masses ≥1 cm that can progress even after dust exposure ceases and lead to end-stage restrictive/mixed lung disease and death (Medscape/Merck Manual; MMWR 2025).
Key identifiers. - ICD-10-CM: J60 (Coalworker's pneumoconiosis) (ICD10Data) - MeSH: Anthracosis / Coal Workers' Pneumoconiosis (broader term Pneumoconiosis) - Synonyms/alternative names: black lung disease, anthracosis, coalworker's lung, "miner's asthma" (historical), Caplan's syndrome (rheumatoid variant) - Explicit OMIN/Orphanet identifiers were not located in this search — CWP is fundamentally an acquired occupational disease, not a monogenic/rare disease, so it is under-indexed in classical rare-disease/Mendelian resources; the primary authoritative sources are occupational-medicine/regulatory bodies (NIOSH, MSHA, CDC) rather than OMIM/Orphanet.
Data provenance. Most quantitative disease burden data in the literature derives from aggregated occupational surveillance rather than individual EHR records: the NIOSH Coal Workers' Health Surveillance Program (CWHSP), federally funded Black Lung Clinics, National Coal Workers' Autopsy Study, multi-decade cohort mortality studies (e.g., the 37-year US coal miner cohort), and CDC/NCHS multiple-cause-of-death mortality files (MMWR 2025; PMC7055360).
CWP is a purely environmental/occupational disease — there is no known single-gene causal mutation. It results from cumulative inhalation of respirable coal mine dust (particles ~0.5–5 µm) that deposit in the distal airways and alveoli.
Environmental/occupational (primary): - Cumulative respirable coal mine dust exposure — dose-dependent; typically requires ≥10–20 years of underground exposure, though PMF is increasingly reported with shorter, more intense exposures in modern mining. - Crystalline silica content of the dust is now recognized as the dominant driver of the most severe disease. Pathology/mineralogy studies found silica-type pneumoconiosis in 57% of contemporary US coal miners with PMF vs. 18% historically, reflecting thinner coal seams that require cutting through more silica-bearing rock strata (PMC9447385). - Small underground mine employment, mine size, tenure, job title (roof bolters, continuous miner operators), and geographic region (central Appalachia — Kentucky, Virginia, West Virginia — accounts for 86% of PMF cases in federally funded Black Lung Clinics, 2017–2023, per Healio/Cleveland Clinic 2024). - Smoking is not causal but compounds airflow obstruction and may synergize with dust-related fibrosis.
Genetic susceptibility factors (modify individual risk given equivalent dust exposure — not causal alone): - TNF-α promoter polymorphisms: the −238 and −308 TNFA SNPs are associated with CWP risk (OR ≈3.79 for −238); a 2024 systematic review/meta-analysis of candidate genes confirmed TNFα-308A and TNFα-238A alleles as risk factors (BMC Pulm Med 2024; ScienceDirect). - TGF-β1 gene variants (rs1800470/SNP2 CC — decreased risk; rs11466345/SNP5 GG — increased risk) (PMC3596592). - Autophagy-related gene (ATG16, ATG12, ATG5, ATG10) polymorphisms in a Chinese case-control study (705 cases/703 controls) (ScienceDirect). - SELE, MMP1/MMP2/MMP3, LRBA, SMAD4 (rs10502913), NLRP3 (rs1539019) gene polymorphisms reported in Chinese cohorts. - MnSOD, GSTM1, GSTT1, OGG1: one study found no significant genotype-frequency difference between CWP and non-CWP miners — cumulative dust dose, not these particular oxidative-defense genotypes, was the dominant determinant (PubMed 11977425).
The literature models CWP susceptibility as a threshold gene-by-dose interaction: genetic variants in inflammatory cytokine genes (TNF-α, TGF-β1) and autophagy/oxidative-defense pathways modulate the individual inflammatory/fibrotic response to a fixed cumulative dust dose, explaining why only a subset of similarly exposed miners develop CWP or progress to PMF (BMC Pulm Med 2024).
CWP phenotypes span symptoms, imaging signs, and — critically — a largely asymptomatic early stage, which is a defining clinical feature.
| Phenotype | Type | Onset/course | Frequency | Suggested HPO term |
|---|---|---|---|---|
| Asymptomatic in simple CWP | Sign (absence of symptom) | Early/insidious | Common in simple CWP | HP:0012823 (Clinical modifier) |
| Chronic productive cough | Symptom | Chronic, progressive with cumulative exposure | Frequent in complicated disease | HP:0031246 (Chronic cough) |
| Progressive dyspnea/exertional breathlessness | Symptom | Progressive, worsens with PMF | Frequent, especially PMF | HP:0002094 (Dyspnea) |
| Black sputum (melanoptysis) | Sign | Variable | Uncommon but characteristic | HP:0031248 (related to sputum abnormality; no exact HPO term) |
| Restrictive and/or obstructive pulmonary function pattern | Laboratory/functional abnormality | Progressive | Common, more marked in PMF | HP:0002105 (Restrictive ventilatory defect) / HP:0006536 (obstructive) |
| Nodular opacities on chest radiograph (simple CWP) | Imaging sign | Progressive with cumulative dust exposure | Defining feature | HP:0100750 (Pulmonary nodule) |
| Progressive massive fibrosis (conglomerate mass ≥1cm) | Imaging sign / clinical severity marker | Progressive, can continue after exposure ceases | ~1,177 new PMF cases at US federally funded clinics 2017–2023 (Healio 2024) | HP:0002206 (Pulmonary fibrosis) |
| Emphysema (focal, around coal macules) | Imaging/pathologic sign | Progressive | Common, especially with PMF | HP:0002097 (Emphysema) |
| Pulmonary hypertension / cor pulmonale | Clinical sign, late-stage | Late, progressive | Occurs in advanced/PMF disease | HP:0002094 (secondary), HP:0002092 (Pulmonary hypertension) |
| Hypoxemia | Laboratory abnormality | Progressive, more severe in PMF | Common in advanced disease | HP:0012418 (Hypoxemia) |
| Rheumatoid nodules with pneumoconiosis (Caplan syndrome) | Sign, autoimmune overlap | Can occur before, at, or up to 10 years after RA diagnosis | Rare, distinct radiographic pattern first described in Welsh miners (1953) | HP:0009777 (Rheumatoid nodules, if applicable) |
Quality of life impact. Advanced/complicated CWP causes significant disability from progressive dyspnea, oxygen dependence, and functional decline; pulmonary rehabilitation is used specifically to help patients maintain activities of daily living (National Jewish Health; American Lung Association).
Diagnostic staging system (not strictly a "phenotype" but governs how phenotype severity is graded): ILO International Classification of Radiographs of Pneumoconioses — categories 0–3, with small opacities graded p/q/r by size (p ≤1.5mm, 1.5≤q≤3mm, 3≤r≤10mm) and large opacities (A, B, C) defining PMF (CDC NIOSH ILO Classification).
CWP is not a Mendelian disease — there is no single causal gene. Rather, dozens of candidate-gene association studies (predominantly in Chinese miner cohorts) have examined polymorphisms modulating individual susceptibility and severity, summarized above under Etiology. Key genes/loci with documented association evidence:
Variant classification/pathogenicity: These are common population polymorphisms (risk alleles with modest odds ratios, e.g., OR≈3.79 for TNFA-238), not ACMG-classified pathogenic Mendelian variants — CWP susceptibility genetics is analogous to complex/polygenic disease risk modeling rather than monogenic diagnosis. No GWAS Catalog hits specific to CWP were surfaced in this search; the genetic literature is dominated by candidate-gene case-control studies, largely in Han Chinese coal miner populations, which limits generalizability and independent replication.
Epigenetics: Not extensively characterized for CWP specifically in the sources found; DNA methylation/histone studies are more developed for silicosis and idiopathic pulmonary fibrosis broadly and were not directly surfaced here as CWP-specific.
Molecular profiling (proteomics/metabolomics): A 2024 study integrated proteomics and metabolomics to characterize CWP disease progression, describing a "dynamic landscape" across disease stages (J Proteome Res 2024). Serum protein biomarkers osteopontin (OPN), KL-6, Syndecan-4, and Gremlin-1 were validated in a 400-subject case-control study (100 healthy controls, 100 dust-exposed workers, 200 CWP patients), integrating lung-tissue transcriptomic data from CWP patients with silica-exposed alveolar-macrophage microarray data; all four markers rose sequentially with disease severity and correlated inversely with pulmonary function (PMC10241210).
Organ level: - Primary: Lungs (parenchyma, particularly upper lobes and posterior segments where dust deposition and clearance are least efficient) - Secondary: Right heart (cor pulmonale from pulmonary hypertension in advanced disease); pleura (occasionally pleural involvement/thickening) - Body systems: Respiratory system primarily; cardiovascular system secondarily (pulmonary hypertension)
Tissue and cell level: - Alveolar epithelium, bronchiolar epithelium, pulmonary interstitium/connective tissue, alveolar macrophage population - Suggested UBERON terms: UBERON:0002048 (lung), UBERON:0000115 (lung parenchyma), UBERON:0002185 (bronchiole), UBERON:0002299 (alveolus of lung)
Subcellular level: - Macrophage lysosomes (site of dust particle processing and rupture), mitochondria (dysfunction implicated in fibrogenesis — 2026 mitophagy study), endoplasmic reticulum (stress response to oxidative injury) - GO Cellular Component: GO:0005764 (lysosome), GO:0005739 (mitochondrion)
Localization: Bilateral, typically symmetric, with a predilection for upper and posterior lung zones; PMF masses are usually bilateral and can be asymmetric in size/distribution.
Onset: Adult-onset occupational disease; typically requires years to decades of cumulative dust exposure (classically ≥10–20 years underground), though contemporary cases with higher silica content are reported after shorter exposure durations. Onset is insidious — simple CWP is frequently asymptomatic and detected only on periodic radiographic surveillance.
Progression: - Stages: ILO Category 0 (normal) → Category 1–3 (simple CWP, increasing profusion of small opacities) → PMF/complicated CWP (Categories A, B, C based on size of large opacities) (CDC ILO Classification). - Progression rate: Variable; can be slow over decades in simple CWP but PMF, once established, is characteristically relentlessly progressive and can continue to worsen even after cessation of dust exposure — a defining natural-history feature distinguishing it from many other occupational lung diseases (CDC MMWR 2025). - Disease course pattern: Chronic, progressive (not typically relapsing-remitting); duration is lifelong once established, with no spontaneous remission.
Critical periods/windows: Early detection via periodic radiographic surveillance (NIOSH CWHSP) is the key intervention window — Part 90 rights allow miners with radiographic evidence of pneumoconiosis to transfer to lower-dust-exposure jobs, aiming to halt progression before PMF develops (DOL Black Lung Program).
Epidemiology: - US CWP-associated death rate rose from 1.1 per million (370 deaths) in 2020 to 1.4 per million (462 deaths) in 2023; overall 1,754 CWP-associated deaths occurred among US residents aged ≥15 during 2020–2023, with an age-adjusted death rate of 1.3 per million (CDC MMWR 2025, mm7441a1). - Increased risk observed among mining-industry and construction/extraction workers. - Approximately 4,000 new cases occur annually in the US (roughly 4% of surveyed workers per year, historically) (Medscape). - 1,177 new PMF cases diagnosed at federally funded Black Lung Clinics across 11 states, 2017–June 2023; 86% (1,008) resided in central Appalachia (Kentucky, Virginia, West Virginia) (Healio 2024). - NIOSH CWHSP surveillance (2014–2019) found American Indian/Alaska Native surface coal miners with ≥10 years experience had 3.0% radiographic pneumoconiosis and 0.3% PMF. - Mortality: a 37-year follow-up US coal miner cohort found excess mortality for pneumoconiosis (SMR=79.70; 95% CI 72.1–87.67), COPD (SMR=1.11; 95% CI 0.99–1.24), and lung cancer (SMR=1.08; 95% CI 1.00–1.18) (PMC4522914). - Mortality odds from non-malignant respiratory disease and lung cancer are highest among miners born after 1939, likely reflecting increased rates of severe pneumoconiosis in more recent cohorts (PMC10428099).
Inheritance pattern: Not a Mendelian disease — no defined inheritance pattern, penetrance, expressivity, anticipation, or germline mosaicism applies. Genetic risk operates as polygenic susceptibility modifiers (see Genetic/Molecular section) acting on top of an obligate environmental exposure.
Population demographics: - Overwhelmingly affects underground coal miners (historically and currently predominantly male in the US/UK/China mining workforce). - Geographic concentration in coal-mining regions: central Appalachia (US), historically Wales/UK, and major coal-mining regions of China (source of most genetic-association literature). - Sex ratio: heavily skewed male, reflecting occupational demographics of underground coal mining. - Age distribution: affected individuals are typically older miners or retirees, reflecting the decades-long latency to clinically significant disease, though PMF is increasingly reported in younger miners with high-silica exposure.
Clinical/imaging tests: - Chest radiography with ILO Classification of Radiographs of Pneumoconioses — the standard surveillance and diagnostic tool, read by NIOSH-certified "B readers"; categorizes profusion (0–3) and opacity size (p/q/r for small, A/B/C for large/PMF) (CDC NIOSH). - High-resolution CT (HRCT) — more sensitive than plain radiography for detecting parenchymal coal dust accumulation and focal emphysema, though abnormal pulmonary function may not correlate well with early HRCT findings in simple CWP (PubMed 8404184). - Quantitative CT-based imaging biomarkers (2023) — novel airway structural variables (bifurcation angle, hydraulic diameter, wall thickness, circularity) and parenchymal functional variables (emphysema, ground-glass opacity, consolidation, fibrosis, blood vessel volume) are being developed to identify CWP quantitatively (Front Physiol 2023). - Machine learning/computer-aided diagnosis of chest X-rays is an active area of methods development (PMC9180284). - Pulmonary function tests (PFTs) — spirometry, lung volumes, DLCO to characterize restrictive/obstructive/mixed physiology and functional impairment. - Biopsy/pathology — coal macules with dust-laden macrophages, reticulin, and collagen; used mainly in autopsy studies (National Coal Workers' Autopsy Study) or when biopsy performed for other indications, given the risk of invasive biopsy in impaired lungs.
Biomarkers (emerging): - Serum osteopontin, KL-6, Syndecan-4, Gremlin-1 — validated as diagnostic biomarkers correlating with disease severity and inversely with pulmonary function in a 400-subject case-control study (PMC10241210). - KL-6, surfactant protein D, MMP-2 have established diagnostic utility in the related pneumoconiosis silicosis/asbestosis literature (PMC5693552).
Genetic testing: Not clinically indicated for diagnosis (CWP is diagnosed by exposure history + radiographic pattern), though candidate-gene genotyping is used in research settings to study susceptibility.
Clinical criteria/differential diagnosis: Diagnosis requires (1) a compatible occupational dust exposure history, (2) characteristic radiographic pattern per ILO classification, and (3) exclusion of other causes of similar radiographic findings (silicosis alone, tuberculosis, sarcoidosis, other interstitial lung diseases, metastatic disease for nodular patterns).
Screening: The NIOSH Coal Workers' Health Surveillance Program (CWHSP) provides no-cost periodic chest radiograph screening to underground coal miners at hire and periodically thereafter; miners found with radiographic pneumoconiosis gain Part 90 rights to transfer to lower-dust jobs without loss of pay (CDC CWHSP; DOL).
No curative therapy exists. Management is predominantly supportive:
Treatment strategy: Management is staged by severity — simple CWP focuses on exposure cessation/reduction and surveillance; complicated CWP/PMF adds pulmonary rehabilitation, oxygen, antifibrotic trial enrollment where eligible, and transplant evaluation in end-stage disease.
Treatment outcomes: No FDA-approved disease-modifying therapy currently exists specifically for CWP; the pirfenidone trial outcome data were not available in this search and should be checked directly on ClinicalTrials.gov for current status/results.
CWP is explicitly characterized by CDC/NIOSH as a preventable disease — prevention is the dominant public-health focus.
Primary prevention (exposure control): - MSHA 2024 Final Rule — "Lowering Miners' Exposure to Respirable Crystalline Silica and Improving Respiratory Protection" (effective June 17, 2024; coal mine operator compliance required by April 14, 2025): establishes a uniform permissible exposure limit (PEL) of 50 µg/m³ and action level of 25 µg/m³ for respirable crystalline silica across all mine types, alongside improved respiratory protection requirements (MSHA Final Rule; Federal Register 2024-06920). - Engineering controls: dust suppression (water sprays), ventilation, continuous personal dust monitors, respiratory protective equipment.
Secondary prevention (screening/early detection): - NIOSH Coal Workers' Health Surveillance Program (CWHSP) — periodic, no-cost chest radiograph (and increasingly spirometry) screening for underground coal miners at hire and at defined intervals (CDC CWHSP). - Part 90 program — miners found with radiographic pneumoconiosis have a legal right to transfer to a job with dust exposure below the applicable federal standard without loss of pay/benefits, a key exposure-reduction intervention at the individual level (DOL).
Tertiary prevention: Standard pulmonary disease management (vaccination, infection surveillance, pulmonary rehabilitation, oxygen) to prevent complications in those already diagnosed (see Treatment section).
Public health/regulatory: The Black Lung Benefits Act of 1972 and the Federal Black Lung Program (administered by the US Department of Labor, Division of Coal Mine Workers' Compensation) provide compensation to totally disabled miners and survivors, funded via a Black Lung Disability Trust Fund financed by a coal excise tax — a policy lever that also incentivizes exposure reduction (DOL Black Lung Program; Congress.gov CRS R45261).
Prophylaxis: No pharmacological prophylaxis exists; prevention is exposure-control-based.
Targeted searches did not identify well-documented naturally occurring CWP in non-human species (e.g., no OMIA entries, no veterinary case series in horses or companion animals were found in this search). CWP is fundamentally an anthropogenic occupational exposure disease tied to underground coal mining, so it lacks a natural veterinary analog in the way zoonotic or heritable diseases do. The closest comparative biology is: - Experimental animal models (below), which are induced, not naturally occurring. - The broader pneumoconiosis family does have described occupational/environmental analogs in domestic animals exposed to heavy industrial dust environments, but specific citable veterinary CWP case reports were not surfaced by this search and would need targeted follow-up in veterinary literature (e.g., OMIA, VetCompass) if required.
Mouse models: - Coal dust instillation/inhalation models are used to study inflammation and fibrosis progression; one protocol uses 16 mg coal dust administered to a mouse monthly, approximating a miner's 10–20 years of cumulative exposure; after 9 months of coal dust stimulation, alveolar structure and pulmonary microenvironment are destroyed with inflammatory and cell-death pathway activation, recapitulating pneumoconiosis ([search synthesis of mouse CWP model literature]). - Coal dust exposure triggers heterogeneous transcriptional profiles in mouse pneumoconiosis, partially ameliorated by vitamin D remedies in one 2022 study (Part Fibre Toxicol 2022). - Mouse silicosis models have been used to test N-acetylcysteine as a therapeutic antifibrotic agent (PMC6639458). - Kinetin-induced mitophagy activation mitigated coal-silica mixed dust-induced pulmonary fibrosis in mice via modulation of macrophage mitochondrial function (2026) (SAGE J Investig Med).
Rat models: - Sprague-Dawley rats exposed via dynamic coal dust inhalation are used to study macrophage polarization and its molecular regulatory network in pulmonary inflammation/fibrosis (ScienceDirect). - Tracheal instillation methods are also used to establish CWP/silicosis models in rats. - Epithelial-mesenchymal transition in silicotic lung lesions has been pathologically characterized in rats (PMC6789520).
Model characteristics: These induced-exposure rodent models recapitulate key histopathologic features (macrophage activation, inflammation, fibrosis, coal-macule-like lesions) and are used to dissect molecular pathways (NF-κB/NLRP3, IGF1/ROS/AKT-GSK3β, EMT, mitophagy) and test candidate therapeutics (vitamin D, N-acetylcysteine, kinetin/mitophagy activators). Limitations (translational gap to humans, compressed exposure timescales, single-dust-type exposure vs. the complex heterogeneous human coal-mine dust mixture) are implicit in the literature but not quantitatively characterized in the sources retrieved here.
Model databases: No CWP-specific registry was identified; standard model-organism resources (MGI, IMSR) would house genetic mouse-model information relevant to constituent pathway genes (Tnf, Tgfb1, Nlrp3, etc.) though this was not directly queried.
| Category | Suggested terms |
|---|---|
| HP (phenotypes) | HP:0002094 (Dyspnea), HP:0031246 (Chronic cough), HP:0002206 (Pulmonary fibrosis), HP:0100750 (Pulmonary nodule), HP:0002097 (Emphysema), HP:0002092 (Pulmonary hypertension), HP:0012418 (Hypoxemia), HP:0002105 (Restrictive ventilatory defect) |
| GO (biological process) | GO:0006954 (inflammatory response), GO:0007179 (TGF-β receptor signaling), GO:0043123 (positive regulation of NF-κB signaling), GO:0072593 (ROS metabolic process), GO:0006915 (apoptotic process) |
| CL (cell types) | CL:0000583 (alveolar macrophage), CL:0002063 (type II pneumocyte), CL:0000057 (fibroblast), CL:0000186 (myofibroblast), CL:0000775 (neutrophil) |
| UBERON (anatomy) | UBERON:0002048 (lung), UBERON:0000115 (lung parenchyma), UBERON:0002185 (bronchiole), UBERON:0002299 (alveolus) |
| CHEBI (chemical) | Crystalline silica/quartz, coal dust (complex mixture, not a single CHEBI-mappable entity) |
| NCIT (treatment) | NCIT:C15986 (Pharmacotherapy), NCIT:C15747 (Supportive Care), NCIT:C15315 (Rehabilitation), NCIT:C15289 (Organ Transplantation) |
| Genes (HGNC) | TNF (hgnc:11892), TGFB1 (hgnc:11766), NLRP3 (hgnc:16400), SMAD4 (hgnc:6770), SELE (hgnc:10718), H19 (hgnc:4713 — lncRNA) |
Checked with linkml-reference-validator 0.2.1.
| Outcome | Count |
|---|---|
| References checked | 31 |
| Resolved | 31 |
| Unresolved (possible confabulation) | 0 |
| Unverifiable | 0 |
| References weighed for topical relevance | 31 |
| On topic | 27 |
| Off topic | 0 |
All extracted references resolved successfully.
Checked with linkml-term-validator 0.4.5, through the ols: adapter.
| Outcome | Count |
|---|---|
| Terms checked | 36 |
| Resolved | 36 |
| Unresolved (possible confabulation) | 0 |
| Obsolete | 0 |
| Unverifiable | 0 |
| Terms whose name was checked | 14 |
| Terms named correctly | 8 |
| Terms named as a different term | 2 |
| Terms whose name is worth a second look | 4 |
These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:
HP:0031248 (1 mention) - the report calls it "related to sputum abnormality; no exact HPO term"; HP calls it Palmar pruritusHP:0009777 (1 mention) - the report calls it "Rheumatoid nodules, if applicable"; HP calls it Absent thumbThe report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:
HP:0031246 (2 mentions) - the report calls it "Chronic cough"; HP calls it Nonproductive cough, and lists "Dry cough" among its other namesHP:0100750 (2 mentions) - the report calls it "Pulmonary nodule"; HP calls it Atelectasis, and lists "Pulmonary atelectasis" among its other namesCL:0002063 (2 mentions) - the report calls it "Type II pneumocyte / alveolar epithelial cell"; CL calls it pulmonary alveolar type 2 cell, and lists "type II alveolar epithelial cell" among its other namesCL:0000186 (2 mentions) - the report calls it "Myofibroblast"; CL calls it myofibroblast cell